<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1662-4548</issn>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26903789</article-id>
<article-id pub-id-type="pmc">4742554</article-id>
<article-id pub-id-type="doi">10.3389/fnins.2016.00020</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Autism Spectrum Disorders and Drug Addiction: Common Pathways, Common Molecules, Distinct Disorders?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rothwell</surname>
<given-names>Patrick E.</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/218204/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff>
<institution>Department of Neuroscience, University of Minnesota</institution>
<country>Minneapolis, MN, USA</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Gul Dolen, Johns Hopkins University, USA</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Andrew K. Ottens, Virginia Commonwealth University, USA; Fadi A. Zaraket, American University of Beirut, Lebanon</p>
</fn>
<corresp id="fn001">*Correspondence: Patrick E. Rothwell <email xlink:type="simple">rothwell@umn.edu</email></corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Systems Biology, a section of the journal Frontiers in Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>10</volume>
<elocation-id>20</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>7</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>1</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Rothwell.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Rothwell</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Autism spectrum disorders (ASDs) and drug addiction do not share substantial comorbidity or obvious similarities in etiology or symptomatology. It is thus surprising that a number of recent studies implicate overlapping neural circuits and molecular signaling pathways in both disorders. The purpose of this review is to highlight this emerging intersection and consider implications for understanding the pathophysiology of these seemingly distinct disorders. One area of overlap involves neural circuits and neuromodulatory systems in the striatum and basal ganglia, which play an established role in addiction and reward but are increasingly implicated in clinical and preclinical studies of ASDs. A second area of overlap relates to molecules like Fragile X mental retardation protein (FMRP) and methyl CpG-binding protein-2 (MECP2), which are best known for their contribution to the pathogenesis of syndromic ASDs, but have recently been shown to regulate behavioral and neurobiological responses to addictive drug exposure. These shared pathways and molecules point to common dimensions of behavioral dysfunction, including the repetition of behavioral patterns and aberrant reward processing. The synthesis of knowledge gained through parallel investigations of ASDs and addiction may inspire the design of new therapeutic interventions to correct common elements of striatal dysfunction.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>addiction</kwd>
<kwd>striatum</kwd>
<kwd>accumbens</kwd>
<kwd>synapse</kwd>
<kwd>dopamine</kwd>
<kwd>medium spiny neuron</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Office of Extramural Research, National Institutes of Health<named-content content-type="fundref-id">10.13039/100006955</named-content></funding-source>
<award-id rid="cn001">K99DA037279</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="0"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="147"></ref-count>
<page-count count="12"></page-count>
<word-count count="11076"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Autism spectrum disorders (ASDs) are prevalent and devastating neuropsychiatric conditions with a pathophysiology that remains poorly understood. The high heritability of ASDs has motivated the widespread application of advanced sequencing technology to identify genetic variants associated with these disorders (McCarroll and Hyman, <xref ref-type="bibr" rid="B88">2013</xref>). The resulting data sets have revealed an extremely complex genetic architecture, including many genes that each contribute to a fraction of cases (Chen et al., <xref ref-type="bibr" rid="B26">2015</xref>). To sift through this complexity, a growing number of studies have taken genetic variants identified in human patients with ASDs, and introduced corresponding mutations into the genome of laboratory mice. Mice carrying genetic variants associated with neuropsychiatric disease provide an opportunity to probe brain function in a highly specific fashion, and explore underlying mechanisms in a manner that can inform the rational design of therapeutics (Fuccillo et al., <xref ref-type="bibr" rid="B48">2016</xref>). In terms of modeling complex disorders like ASDs, a significant strength of this approach is the construct validity provided by studying genetic variants in mice with known ASD association in humans (Nestler and Hyman, <xref ref-type="bibr" rid="B93">2010</xref>). Mice carrying ASD-associated genetic mutations also exhibit behavioral phenotypes that map onto primary ASD symptom domains, including reduced social interaction and repetitive patterns of behavior (Silverman et al., <xref ref-type="bibr" rid="B120">2010</xref>), providing an additional degree of face validity. Some of these behavioral phenotypes can be corrected by drugs approved for treatment of ASDs in humans (e.g., Peñagarikano et al., <xref ref-type="bibr" rid="B101">2011</xref>), although the limited number of effective medications precludes more rigorous evaluation of predictive validity.</p>
<p>Many of the genes associated with ASDs play a role in regulating synaptic transmission between neurons (Zoghbi and Bear, <xref ref-type="bibr" rid="B147">2012</xref>), including synaptic cell adhesion molecules like neurexins and neuroligins (Südhof, <xref ref-type="bibr" rid="B128">2008</xref>), as well as postsynaptic scaffolding molecules like SHANK (Jiang and Ehlers, <xref ref-type="bibr" rid="B71">2013</xref>). The generation of mouse lines carrying these ASD-associated genetic mutations has provided opportunities to evaluate changes in synaptic transmission across a variety of brain regions. The emerging synaptic architecture of ASDs is nearly as complex as its genetic architecture, with little consistency when phenotypes are compared across different brain regions or different ASD-associated mutations. For instance, the same genetic mutation can produce distinct functional changes at different synapses (Etherton et al., <xref ref-type="bibr" rid="B41">2011</xref>; Földy et al., <xref ref-type="bibr" rid="B45">2013</xref>), and the same synaptic process can be oppositely affected by different mutations (Auerbach et al., <xref ref-type="bibr" rid="B6">2011</xref>). These perplexing results highlight the importance of winnowing down the essential synaptic circuits that contribute to ASD pathogenesis.</p>
<p>One such critical pathway may involve the striatum and interconnected basal ganglia nuclei, which have been implicated by a number of recent mouse studies, and exhibit functional and structural changes in human patients with ASDs that often correlate with symptom severity (e.g., Sears et al., <xref ref-type="bibr" rid="B116">1999</xref>; Hollander et al., <xref ref-type="bibr" rid="B64">2005</xref>; Rojas et al., <xref ref-type="bibr" rid="B108">2006</xref>; Voelbel et al., <xref ref-type="bibr" rid="B136">2006</xref>; Langen et al., <xref ref-type="bibr" rid="B82">2009</xref>, <xref ref-type="bibr" rid="B79">2014</xref>; Delmonte et al., <xref ref-type="bibr" rid="B31">2012</xref>; Abrams et al., <xref ref-type="bibr" rid="B1">2013</xref>). This growing literature on striatal dysfunction in ASDs has, rather surprisingly, implicated pathways and circuit elements known to play a role in drug addiction. The development and progression of addiction have long been tied to a number of striatal neurochemical systems (e.g., Wise, <xref ref-type="bibr" rid="B141">1987</xref>; Koob and Bloom, <xref ref-type="bibr" rid="B76">1988</xref>; Sarnyai and Kovacs, <xref ref-type="bibr" rid="B113">1994</xref>). More recently, chronic drug exposure has been shown to cause changes in the structure and function of striatal synapses (Russo et al., <xref ref-type="bibr" rid="B110">2010</xref>; Grueter et al., <xref ref-type="bibr" rid="B55">2012</xref>), and these forms of drug-evoked synaptic plasticity contribute to a variety of addiction-related behaviors in rodents. Several recent studies suggest genes and molecules canonically associated with ASDs function in the striatum to regulate drug-evoked synaptic and behavioral plasticity in addiction models - another surprising connection between these seemingly distinct disorders.</p>
<p>The purpose of this article is to review the emerging intersection between ASDs and addiction in the striatum, and consider potential implications for the pathophysiology and treatment of both disorders. Many of the topics covered below relate recent publications in the realm of ASDs to longstanding or established concepts in addiction research, though recent examples of addiction research are included when appropriate. The topics and references are drawn from personal familiarity with both fields of research, as well as manual review of literature searches including autism and addiction, autism and striatum, or autism and each of the various signaling pathways discussed below. The manuscript is organized on the basis of emerging common themes, and thus represents an integrative review of select literature that highlights areas of overlap and potential shared mechanisms, rather than a comprehensive or systematic review of research on either ASDs or addiction (Whittemore et al., <xref ref-type="bibr" rid="B140">2014</xref>).</p>
</sec>
<sec id="s2">
<title>Striatal pathways in ASDs</title>
<p>The striatum serves as a gateway to the basal ganglia, receiving synaptic input from numerous cortical, thalamic, and limbic brain regions, and relaying information to downstream processing stations in the basal ganglia (Sesack and Grace, <xref ref-type="bibr" rid="B117">2010</xref>; Nelson and Kreitzer, <xref ref-type="bibr" rid="B92">2014</xref>). In humans and primates, the striatal complex includes the caudate nucleus, the putamen, and a ventral striatal region known as the nucleus accumbens. In rodents, the nucleus accumbens also occupies the ventral portion of striatum, while the caudate and putamen roughly correspond to medial and lateral subregions of the dorsal striatum, respectively (Graybiel, <xref ref-type="bibr" rid="B53">2008</xref>). Of these striatal subregions, the nucleus accumbens is most closely associated with reward-related behavioral functions (Carlezon and Thomas, <xref ref-type="bibr" rid="B21">2009</xref>; Sesack and Grace, <xref ref-type="bibr" rid="B117">2010</xref>). Many of these functions pertain to learning reward-related associations, either in terms of cues that predict delivery of reward (classical/Pavlovian conditioning), or actions that must be completed to obtain reward (operant/instrumental conditioning). In human brain imaging studies, normal reward-related activation of the nucleus accumbens is disturbed in patients with ASDs (e.g., Scott-Van Zeeland et al., <xref ref-type="bibr" rid="B115">2010</xref>; Delmonte et al., <xref ref-type="bibr" rid="B31">2012</xref>; Dichter et al., <xref ref-type="bibr" rid="B36">2012</xref>; Kohls et al., <xref ref-type="bibr" rid="B74">2013</xref>; Richey et al., <xref ref-type="bibr" rid="B106">2014</xref>).</p>
<p>Dorsal striatal subregions also play a role in processing reward, particularly in terms of the movements and actions that must be learned and executed in order to obtain reward (Balleine et al., <xref ref-type="bibr" rid="B7">2007</xref>). A number of important dissociations have been reported in the behavioral functions of dorsomedial and dorsolateral striatum in rodents (Yin and Knowlton, <xref ref-type="bibr" rid="B145">2006</xref>; Balleine and O'Doherty, <xref ref-type="bibr" rid="B8">2010</xref>). The model emerging from these studies suggests that dorsomedial striatum is important for behaviors that are flexible and sensitive to outcome, which is often the case early in learning. As actions are repeated many times and become streamlined and automatic, they also become less sensitive to outcome, and this late stage of learning involves dorsolateral striatum. These inflexible and ingrained patterns of behavior are considered “habitual,” and the process of habit formation could contribute to some of the repetitive and stereotyped routines and rituals observed in patients with ASDs. Indeed, many studies have reported structural and functional alterations in the caudate and putamen of human patients with ASDs (e.g., Sears et al., <xref ref-type="bibr" rid="B116">1999</xref>; Eliez et al., <xref ref-type="bibr" rid="B39">2001</xref>; Levitt et al., <xref ref-type="bibr" rid="B83">2003</xref>; Hollander et al., <xref ref-type="bibr" rid="B64">2005</xref>; Haznedar et al., <xref ref-type="bibr" rid="B59">2006</xref>; Silk et al., <xref ref-type="bibr" rid="B119">2006</xref>; Turner et al., <xref ref-type="bibr" rid="B133">2006</xref>; Voelbel et al., <xref ref-type="bibr" rid="B136">2006</xref>; Langen et al., <xref ref-type="bibr" rid="B80">2007</xref>, <xref ref-type="bibr" rid="B81">2012</xref>; Takarae et al., <xref ref-type="bibr" rid="B129">2007</xref>; Di Martino et al., <xref ref-type="bibr" rid="B35">2011</xref>).</p>
<p>Many robust behavioral assays for striatum-dependent reward processing have been developed in rodents. One example is the place conditioning assay, which involves the association between a rewarding stimulus and a distinct set of contextual cues (e.g., floor texture, wall pattern, or chamber odor). The choice to spend time in the presence of these cues vs. a neutral set of cues is operationally defined as a conditioned place preference (CPP), and most drugs of abuse produce CPP (Tzschentke, <xref ref-type="bibr" rid="B134">1998</xref>). Rodents will also develop CPP for contextual cues associated with social interaction with conspecifics, relative to cues experienced during social isolation (Panksepp and Lahvis, <xref ref-type="bibr" rid="B97">2007</xref>; Trezza et al., <xref ref-type="bibr" rid="B132">2009</xref>). This preference for cues associated with social interactions (i.e., “social CPP”) is likely related to the preference for pair-bonded partners exhibited by monogamous species like prairie voles (Carter et al., <xref ref-type="bibr" rid="B23">1995</xref>) and titi monkeys (Carp et al., <xref ref-type="bibr" rid="B22">2015</xref>). Many of the same striatal pathways contribute to social behavior as well as drug reward, suggesting neurochemical systems that originally evolved to mediate social attachment may be hijacked by drugs of abuse (Insel, <xref ref-type="bibr" rid="B68">2003</xref>; Burkett and Young, <xref ref-type="bibr" rid="B19">2012</xref>). Recent studies of mice carrying ASD-associated genetic mutations point to dysfunction of these same striatal systems, which will be reviewed below in terms of both basic function as well as dysfunction in ASDs.</p>
<sec>
<title>Oxytocin</title>
<p>The peptide hormone oxytocin contributes to a myriad of social behaviors across many mammalian species (Anacker and Beery, <xref ref-type="bibr" rid="B5">2013</xref>). The pro-social effects of oxytocin have generated substantial interest in its use as a treatment for social deficits associated with ASDs, and there is also some evidence for genetic polymorphisms in the oxytocin receptor associated with ASDs (reviewed by Yamasue et al., <xref ref-type="bibr" rid="B144">2012</xref>). The monogamous behavior of prairie voles is associated with a high density of oxytocin receptors in the nucleus accumbens, and pharmacological blockade of these receptors prevents pair bond formation (reviewed by Insel and Young, <xref ref-type="bibr" rid="B70">2001</xref>), pointing to a key role for oxytocin signaling in the nucleus accumbens in social behavior.</p>
<p>A recent study by Dölen et al. (<xref ref-type="bibr" rid="B37">2013</xref>) found that pharmacological antagonism of oxytocin receptors in the nucleus accumbens also blocks social CPP in mice. This result was somewhat surprising, as mice were previously reported to have a relatively low density of oxytocin receptors in the nucleus accumbens compared to other rodent species (Olazábal and Young, <xref ref-type="bibr" rid="B96">2006</xref>). However, conditional genetic deletion of the oxytocin receptors in the nucleus accumbens itself did not impair social CPP. Instead, the oxytocin receptors that mediate social CPP appeared to be expressed on the axon terminals of serotonergic fibers that originate in the dorsal raphe nucleus, and pharmacological antagonism of serotonin 5HT1B receptors in the nucleus accumbens also blocked social CPP (Dölen et al., <xref ref-type="bibr" rid="B37">2013</xref>).</p>
<p>Synaptic plasticity in the nucleus accumbens may be important for encoding the association between social interaction and contextual cues that leads to social CPP. In acute brain slice preparations, stimulation of either oxytocin or serotonin 5HT1B receptors in the nucleus accumbens produced a long-term depression (LTD) of excitatory synapses onto MSNs (Dölen et al., <xref ref-type="bibr" rid="B37">2013</xref>). This reduction of excitatory synaptic drive was associated with a decrease in the probability of presynaptic glutamate release, and provides a plausible synaptic mechanism that may contribute to social reward. Other forms of nucleus accumbens LTD that involve presynaptic changes in glutamate release are impaired by addictive drug exposure (e.g., Fourgeaud et al., <xref ref-type="bibr" rid="B46">2004</xref>; Grueter et al., <xref ref-type="bibr" rid="B54">2010</xref>). This occlusion could contribute to decrements in social behavior caused by drug exposure, like the impairment of social bonding in prairie voles caused by amphetamine exposure (Liu et al., <xref ref-type="bibr" rid="B84">2010</xref>). This impairment can be reversed by oxytocin administration (Young et al., <xref ref-type="bibr" rid="B146">2014</xref>), and oxytocin can attenuate other behavioral effects of psychostimulant administration (reviewed by Sarnyai and Kovács, <xref ref-type="bibr" rid="B114">2014</xref>), clearly demonstrating an interaction between drug effects and the oxytocin system. However, the neurobiological substrata of social and drug reward are at least partially separable, because pharmacological antagonism of oxytocin receptors does not block cocaine CPP (Dölen et al., <xref ref-type="bibr" rid="B37">2013</xref>).</p>
</sec>
<sec>
<title>Dopamine release</title>
<p>Dopaminergic input to the nucleus accumbens originates from dopamine neurons in the ventral tegmental area of the midbrain, and this “mesolimbic” dopamine pathway is closely tied to motivation, reward, and the development of addiction (for reviews, see Wise, <xref ref-type="bibr" rid="B142">2004</xref>; Berridge, <xref ref-type="bibr" rid="B12">2007</xref>; Salamone and Correa, <xref ref-type="bibr" rid="B111">2012</xref>). Mesolimbic dopamine is also important for social behavior in rodents, including pair bond formation in prairie voles (reviewed by Curtis et al., <xref ref-type="bibr" rid="B29">2006</xref>). In mice, activity of the mesolimbic dopamine pathway corresponds to social behavior in real time, and optogenetic manipulations of this pathway affect social interaction (Gunaydin et al., <xref ref-type="bibr" rid="B56">2014</xref>). Given these critical functions of dopamine in social behavior and reward, it is perhaps not surprising that genetic polymorphisms in dopamine signaling genes are also associated with ASDs (e.g., Comings et al., <xref ref-type="bibr" rid="B27">1991</xref>; Hettinger et al., <xref ref-type="bibr" rid="B62">2008</xref>, <xref ref-type="bibr" rid="B61">2012</xref>; De Krom et al., <xref ref-type="bibr" rid="B30">2009</xref>; Hamilton et al., <xref ref-type="bibr" rid="B58">2013</xref>; Bowton et al., <xref ref-type="bibr" rid="B16">2014</xref>; Staal et al., <xref ref-type="bibr" rid="B125">2015</xref>).</p>
<p>A recent report by Karayannis et al. (<xref ref-type="bibr" rid="B73">2014</xref>) examined the function of the mesolimbic dopamine system in mice following genetic deletion of <italic>Cntnap4</italic> (also known as <italic>Caspr4</italic>), the gene encoding contactin-associated protein-like 4 (Cntnap4). Cntnap4 is a transmembrane protein that belongs to the neurexin superfamily of cell adhesion molecules, which interact with presynaptic proteins involved in neurotransmitter release (Spiegel et al., <xref ref-type="bibr" rid="B124">2002</xref>). Genetic mutations in other members of this family of molecules have been previously reported in patients with ASDs, and Karayannis et al. (<xref ref-type="bibr" rid="B73">2014</xref>) report several new ASD probands with <italic>CNTNAP4</italic> gene disruptions. In mice, they found that expression of Cntnap4 was enriched in midbrain dopamine neurons, as well as inhibitory interneurons in the cerebral cortex, and therefore examined the release of dopamine and GABA from these populations of brain cells. While the release of GABA from cortical interneurons was substantially reduced in <italic>Cntnap4</italic> mutant mice, the release of dopamine in the nucleus accumbens was significantly increased. These divergent effects on release of two different neurotransmitters further underscore the heterogeneous effects that a single ASD-associated genetic mutation can have on different types of synapses.</p>
<p><italic>Cntnap4</italic> mutant mice also exhibited a variety of aberrant behavioral phenotypes (Karayannis et al., <xref ref-type="bibr" rid="B73">2014</xref>). Most striking was hair loss on the snout, face, and body, which was caused by over-grooming of offspring by parents carrying the <italic>Cntnap4</italic> mutation. This excessive grooming phenotype was reversed by chronic treatment with haloperidol, a dopamine D2 receptor antagonist, suggesting over-grooming was caused by excessive dopamine signaling. Social behavior was not assessed by Karayannis et al. (<xref ref-type="bibr" rid="B73">2014</xref>) in <italic>Cntnap4</italic> mutant mice, though it is disrupted by mutations of <italic>Cntnap2</italic>, another member of this protein family (Peñagarikano et al., <xref ref-type="bibr" rid="B101">2011</xref>; Burkett et al., <xref ref-type="bibr" rid="B20">2015</xref>). It will be fascinating to see whether excessive dopamine signaling in the nucleus accumbens of <italic>Cntnap4</italic> mutant mice alters either social reward or behavioral responses to addictive drug exposure.</p>
</sec>
<sec>
<title>Dopamine-sensitive medium spiny neurons</title>
<p>A variety of dopamine receptors are expressed by different cell types in the striatum (Gerfen and Surmeier, <xref ref-type="bibr" rid="B49">2011</xref>). While a small fraction of striatal cells are interneurons that release acetylcholine or GABA, the vast majority of striatal cells are medium spiny projection neurons (MSNs). MSNs are the principal neurons of the striatum and relay information to downstream processing stations in the basal ganglia, including the substantia nigra pars reticulata and the globus pallidus. In the dorsal striatum, striatonigral and striatopallidal MSNs represent two discrete subpopulations that differ in expression of D1 vs. D2 dopamine receptors, as well as a variety of other properties (Gerfen and Surmeier, <xref ref-type="bibr" rid="B49">2011</xref>). The nucleus accumbens also contains discrete populations of D1-MSNs and D2-MSNs, but D1-MSNs in the nucleus accumbens project to both the ventral mesencephalon and ventral pallidum, whereas D2-MSNs project only to the ventral pallidum (Kupchik et al., <xref ref-type="bibr" rid="B77">2015</xref>).</p>
<p>The ability to identify and manipulate specific MSN subtypes was dramatically advanced by the development of bacterial artificial chromosome (BAC) transgenic mice (Heintz, <xref ref-type="bibr" rid="B60">2001</xref>), which allow cell type-specific expression of fluorescent proteins (Gong et al., <xref ref-type="bibr" rid="B52">2003</xref>; Shuen et al., <xref ref-type="bibr" rid="B118">2008</xref>) as well as Cre recombinase (Gong et al., <xref ref-type="bibr" rid="B51">2007</xref>; Durieux et al., <xref ref-type="bibr" rid="B38">2009</xref>). The application of these tools to research on drug addiction has revealed that activation of D1-MSNs promotes addiction-related behaviors, whereas activation of D2-MSNs tends to inhibit the same behaviors (Lobo et al., <xref ref-type="bibr" rid="B85">2010</xref>; Bock et al., <xref ref-type="bibr" rid="B14">2013</xref>; Pascoli et al., <xref ref-type="bibr" rid="B98">2014</xref>; reviewed by Smith et al., <xref ref-type="bibr" rid="B123">2013</xref>). These divergent effects are consistent with classic models of basal ganglia function, in which the direct pathway formed by D1-MSNs and the indirect pathway formed by D2-MSNs exert opposite influences on overall basal ganglia output (Albin et al., <xref ref-type="bibr" rid="B3">1989</xref>; DeLong, <xref ref-type="bibr" rid="B32">1990</xref>).</p>
<p>Striatal MSNs show enriched expression of genes associated with ASDs (Chang et al., <xref ref-type="bibr" rid="B25">2015</xref>), and recent studies have begun to explore how ASD-associated mutations affect specific MSN subtypes. One study focused on ASD-associated mutations in neuroligin-3 (<italic>Nlgn3</italic>), a synaptic cell adhesion molecule that plays important roles in shaping the functional properties of synaptic transmission. Loss-of-function genetic mutations in <italic>Nlgn3</italic> caused a specific impairment of inhibitory synaptic transmission onto nucleus accumbens D1-MSNs (Rothwell et al., <xref ref-type="bibr" rid="B109">2014</xref>). This reduction of inhibitory synaptic transmission is intriguing because human patients with ASDs have been reported to have decreased GABA receptor binding in the nucleus accumbens (Mendez et al., <xref ref-type="bibr" rid="B89">2013</xref>). In mice, nucleus accumbens D1-MSNs appeared to be selectively vulnerable to genetic deletion of <italic>Nlgn3</italic> because it is expressed at a relatively high level compared to neighboring D2-MSNs, or MSNs in the dorsal striatum. Conditional genetic deletion of <italic>Nlgn3</italic> from nucleus accumbens D1-MSNs also caused the development of a more repetitive motor routine on the accelerating rotarod task (Rothwell et al., <xref ref-type="bibr" rid="B109">2014</xref>). This behavioral phenotype has also been reported in several other mouse lines carrying ASD-associated genetic mutations (Kwon et al., <xref ref-type="bibr" rid="B78">2006</xref>; Etherton et al., <xref ref-type="bibr" rid="B42">2009</xref>; Nakatani et al., <xref ref-type="bibr" rid="B91">2009</xref>), and thus might have some relevance to the repetitive and stereotyped movements and routines associated with ASDs in human patients.</p>
<p>Altered striatal structure and function have also been reported in mice lacking the genes normally found on human chromosome 16p11.2 that are deleted in some human patients with ASDs (Weiss et al., <xref ref-type="bibr" rid="B139">2008</xref>). These 16p11 mutant mice have an increased number of striatal cells expressing markers of D2-MSNs, as well as more MSNs co-expressing both D1 and D2 markers, but no change in the number of D1-MSNs (Portmann et al., <xref ref-type="bibr" rid="B104">2014</xref>). These changes in cell number were associated with a relative enlargement in the size of the nucleus accumbens as well as the globus pallidus, which receives synaptic input from D2-MSNs. In 16p11 mutant mice, D2-MSNs also appeared to send ectopic projections to the medial globus pallidus, which is normally only targeted by D1-MSNs. Nucleus accumbens MSNs of 16p11 mutant mice had altered excitatory synaptic properties, including a presynaptic increase in the probability of glutamate release and changes in postsynaptic glutamate receptor complement. Mutant mice also exhibited behavioral phenotypes that included hyperactivity, circling, and a lack of habituation to novelty.</p>
</sec>
<sec>
<title>Opioids</title>
<p>Striatal opioid systems play an important role in the rewarding aspects of social interaction (Burkett et al., <xref ref-type="bibr" rid="B18">2011</xref>; Trezza et al., <xref ref-type="bibr" rid="B130">2011</xref>; Resendez et al., <xref ref-type="bibr" rid="B105">2013</xref>), as well as the rewarding properties of opiate narcotics and other abused drugs (Befort, <xref ref-type="bibr" rid="B10">2015</xref>). The mu opioid receptor (MOR) is a particularly critical mediator of the rewarding effects of opiates like morphine (Matthes et al., <xref ref-type="bibr" rid="B87">1996</xref>). Juvenile mice lacking the MOR gene (<italic>Oprm1</italic>) exhibit a diminished behavioral response to separation from their mothers, suggesting that interaction with the mother may be less rewarding (Moles et al., <xref ref-type="bibr" rid="B90">2004</xref>). Adult <italic>Oprm1</italic> knockout mice also exhibit other ASD-related behavioral phenotypes, including decreased sociability and stereotyped behaviors (Becker et al., <xref ref-type="bibr" rid="B9">2014</xref>). These behavioral changes were associated with dramatic gene expression changes in the nucleus accumbens and dorsal striatum, including a number of genes involved in excitatory synaptic signaling. One of these genes (<italic>Grm4</italic>) encodes the metabotropic glutamate receptor mGluR4, and administration of an mGluR4 positive allosteric modulator effectively relieved many of the behavioral phenotypes exhibited by MOR knockout mice.</p>
<p>Endogenous opioids may interact with other neuromodulatory systems in the nucleus accumbens. MOR knockout mice exhibit a dramatic decrease in mRNA levels for oxytocin in the NAc (Becker et al., <xref ref-type="bibr" rid="B9">2014</xref>). Conversely, oxytocin receptor levels in the NAc are increased (Gigliucci et al., <xref ref-type="bibr" rid="B50">2014</xref>), which could represent a homeostatic response to compensate for loss of endogenous ligand. Intranasal administration of oxytocin to adult male MOR-KO mice led to an increase in the number of ultrasonic vocalizations emitted during interaction with a female mouse (Gigliucci et al., <xref ref-type="bibr" rid="B50">2014</xref>). This interaction between opioid and oxytocin signaling in the NAc suggests a convergence of multiple signaling pathways that may contribute to ASD pathophysiology.</p>
</sec>
<sec>
<title>Endocannabinoids</title>
<p>Brain cannabinoid receptors are activated by both exogenous and endogenous cannabinoids, and play an important role in drug reward (Befort, <xref ref-type="bibr" rid="B10">2015</xref>). Endogenous cannabinoid systems in the nucleus accumbens also regulate social behavior, as local blockade of endocannabinoid degradation enhances social play (Trezza et al., <xref ref-type="bibr" rid="B131">2012</xref>). Social interaction increases levels of anandamide (an endogenous cannabinoid) in the nucleus accumbens, an effect that is stimulated by oxytocin and may contribute to social reward (Wei et al., <xref ref-type="bibr" rid="B138">2015</xref>). Endocannabinoids are important for regulating synaptic function in a variety of ways, including a key role in many forms of synaptic plasticity. Mice lacking FMRP have an impairment of endocannabinoid-dependent LTD of excitatory synapses in the NAc (Jung et al., <xref ref-type="bibr" rid="B72">2012</xref>). This impairment is due to a mislocalization of diacylglycerol lipase-α (DGL-α), a key enzyme in the biosynthetic pathway for the endocannabinoid 2-arachidonoyl-sn-glycerol (2-AG). In the absence of FMRP, DGL-α is localized farther away from the postsynaptic density and is not robustly activated by stimulation of mGluR5. However, this signaling deficit could be rescued by inhibiting the degradation of 2-AG, leading to a normalization of LTD in the NAc as well as some behavioral phenotypes of FMRP knockout mice. ASD-associated genetic mutations in <italic>Nlgn3</italic> did not appear to affect endocannabinoid-dependent LTD in the nucleus accumbens (Rothwell et al., <xref ref-type="bibr" rid="B109">2014</xref>), though these mutations do alter endocannabinoid signaling in other parts of the brain (Földy et al., <xref ref-type="bibr" rid="B45">2013</xref>). In the dorsal striatum, exaggerated LTD has been reported in mice overexpressing eukaryotic translation initiation factor 4E (Santini et al., <xref ref-type="bibr" rid="B112">2013</xref>), which is encoded by the ASD candidate gene <italic>Eif3e</italic> (Neves-Pereira et al., <xref ref-type="bibr" rid="B95">2009</xref>).</p>
</sec>
<sec>
<title>Pathways to dorsal striatum</title>
<p>The progression of drug abuse is thought to involve a transition in the control of behavior from ventral to dorsal striatum (for a recent review, see Everitt and Robbins, <xref ref-type="bibr" rid="B43">2016</xref>). This transition corresponds with a shift in the motivation to take drugs, which becomes less goal-directed and more compulsive or habitual (i.e., insensitive to outcome), leading to continued use despite adverse consequences. This transition in behavioral control may involve polysynaptic pathways that link ventral striatum with dorsal striatum, as neurons in the nucleus accumbens project to dopaminergic centers in the midbrain that subsequently project to more dorsal striatal subregions (Haber et al., <xref ref-type="bibr" rid="B57">2000</xref>; Ikemoto, <xref ref-type="bibr" rid="B65">2007</xref>). This ascending spiral of connectivity may be engaged over the course of chronic drug use and contribute to habitual patterns of addiction (Belin and Everitt, <xref ref-type="bibr" rid="B11">2008</xref>).</p>
<p>Changes in the nucleus accumbens caused by ASD-associated genetic variants could accelerate the transition of behavioral control to more dorsal striatal subregions, leading to more repetitive, stereotyped, or habitual patterns of behavior. However, changes that directly affect the dorsal striatum may also produce similar behavioral consequences: for example, the exaggeration of dorsal striatal LTD in <italic>Eif3e</italic> mutant mice could potentially affect the process of habit formation (Santini et al., <xref ref-type="bibr" rid="B112">2013</xref>). Dysfunction in the dorsal striatum has also been reported in mice carrying gene deletions of <italic>Shank3</italic> (Peca et al., <xref ref-type="bibr" rid="B100">2011</xref>), which encodes a synaptic scaffolding protein and is disrupted in Phelan-McDermid syndrome (an autism spectrum disorder) as well as idiopathic ASDs (reviewed by Jiang and Ehlers, <xref ref-type="bibr" rid="B71">2013</xref>). These <italic>Shank3</italic> mutant mice exhibit reduced social interaction and excessive self-grooming to the point of skin lesions (Peca et al., <xref ref-type="bibr" rid="B100">2011</xref>). MSNs in the dorsal striatum exhibited abnormal morphology and impaired excitatory synaptic transmission, although it is presently unclear if D1- or D2-MSNs were preferentially affected.</p>
</sec>
</sec>
<sec id="s3">
<title>ASD molecules in addiction</title>
<p>Genes and molecules that have been extensively studied in the realm of ASDs have recently emerged as potential mediators of addiction-related behavior. These include the genes known to cause Rett syndrome (MECP2—Amir et al., <xref ref-type="bibr" rid="B4">1999</xref>) and fragile X syndrome (FMR1—Pieretti et al., <xref ref-type="bibr" rid="B103">1991</xref>), which have been topics of sustained research since their initial identification. MeCP2 and FMRP play important roles in the regulation of gene transcription and translation, respectively. In mice, genetic mutations in <italic>Mecp2</italic> and <italic>Fmr1</italic> cause a variety of deficits in synaptic transmission and plasticity throughout the brain, which are thought to contribute to the ASD-related symptoms frequently observed in patients with these syndromes (Zoghbi and Bear, <xref ref-type="bibr" rid="B147">2012</xref>).</p>
<p>These ASD-associated molecules have been shown to regulate multiple aspects of striatal function. For example, dopamine signaling in the striatum is regulated by both MeCP2 (Su et al., <xref ref-type="bibr" rid="B127">2015</xref>) and FMRP (Wang et al., <xref ref-type="bibr" rid="B137">2008</xref>). Genetic deletion of <italic>Fmr1</italic> also affects synaptic structure, function, and plasticity in the nucleus accumbens (Jung et al., <xref ref-type="bibr" rid="B72">2012</xref>; Smith et al., <xref ref-type="bibr" rid="B122">2014</xref>; Neuhofer et al., <xref ref-type="bibr" rid="B94">2015</xref>) as well as the dorsal striatum (Centonze et al., <xref ref-type="bibr" rid="B24">2008</xref>; Maccarrone et al., <xref ref-type="bibr" rid="B86">2010</xref>). The development of drug addiction is strongly tied to dopamine signaling and synaptic remodeling in the striatum, motivating several recent investigations of how genetic mutations in <italic>Mecp2</italic> and <italic>Fmr1</italic> affect behavioral responses to addictive drugs. These studies focused on common behavioral outcomes in addiction research, including CPP as a measure of drug reward, as well as performance an instrumental response to receive contingent delivery of the drug (i.e., drug self-administration). These studies also examined psychomotor activation following acute drug administration, as well as the psychomotor sensitization that occurs following repeated drug exposure, as these behavioral processes are closely tied to striatal dopamine release and remodeling of striatal circuitry (for reviews, see Vanderschuren and Kalivas, <xref ref-type="bibr" rid="B135">2000</xref>; Grueter et al., <xref ref-type="bibr" rid="B55">2012</xref>).</p>
<sec>
<title>Methyl CpG-binding protein-2 (MeCP2)</title>
<p>Psychostimulant administration induces MeCP2 phosphorylation in the nucleus accumbens (Deng et al., <xref ref-type="bibr" rid="B33">2010</xref>, <xref ref-type="bibr" rid="B34">2014</xref>). This effect is not seen in MSNs, but is instead selective for fast-spiking GABAergic interneurons that express parvalbumin and GAD67. Behavioral responses to amphetamine administration are altered by a constitutive hypomorphic mutation in <italic>Mecp2</italic> (Deng et al., <xref ref-type="bibr" rid="B33">2010</xref>), as well as a Ser421Ala mutation in Mecp2 that prevents psychostimulant-induced phosphorylation (Deng et al., <xref ref-type="bibr" rid="B34">2014</xref>). Enhanced behavioral sensitivity to psychostimulants is also observed following restricted knockdown of <italic>Mecp2</italic> expression in the nucleus accumbens. These findings suggest phosphorylation of MeCP2 in the nucleus accumbens plays a role in constraining behavioral responses to psychostimulants. However, the role of MeCP2 may be different in the dorsal striatum, as a separate study found cocaine self-administration was reduced following restricted knockdown of <italic>Mecp2</italic> expression in the dorsal striatum (Im et al., <xref ref-type="bibr" rid="B66">2010</xref>).</p>
</sec>
<sec>
<title>Fragile X mental retardation protein (FMRP)</title>
<p>Constitutive genetic deletion of <italic>Fmr1</italic> did not alter the acute locomotor response to cocaine, but decreased locomotor sensitization over course of repeated cocaine exposure, and also attenuated cocaine CPP (Smith et al., <xref ref-type="bibr" rid="B122">2014</xref>). Conditional genetic deletion of <italic>Fmr1</italic> in the nucleus accumbens also decreased locomotor sensitization, though it did not affect cocaine CPP. Cocaine-evoked changes in the structure and function of excitatory synapses onto nucleus accumbens MSNs were also enhanced in <italic>Fmr1</italic> constitutive knockout mice. These data suggest that FMRP serves as a negative regulator of the structural and functional changes at nucleus accumbens synapses caused by chronic drug exposure, similar to MeCP2 (Deng et al., <xref ref-type="bibr" rid="B34">2014</xref>).</p>
</sec>
</sec>
<sec id="s4">
<title>Outlook and open questions</title>
<p>How do these emerging parallels between ASDs and addiction (Table <xref ref-type="table" rid="T1">1</xref>) inform our understanding of the pathophysiology of each disorder in relationship to the striatum? Despite these parallels, these are clearly two distinct disorders, as evidenced not only by distinct symptomatology but also the lack of comorbidity. Nevertheless, ongoing research may benefit from more careful consideration of neurobiological and psychological process that may be commonly affected in both disorders. This approach is reminiscent the Research Domain Criterion (RDoC) initiative by the U.S. National Institute of Mental Health (Insel et al., <xref ref-type="bibr" rid="B67">2010</xref>; Insel and Cuthbert, <xref ref-type="bibr" rid="B69">2015</xref>), which aims to establish a new framework for psychiatric research that moves away from specific clinical diagnoses and toward dimensions or constructs with well-defined neurobiological substrata that may be impaired across multiple mental disorders. Below, I consider two behavioral dimensions that may be commonly affected in both ASDs and addiction, as well as potential neural mechanisms and therapeutic implications raised by the shared and distinct elements of these disorders.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p><bold>Striatal signaling pathways and molecules commonly implicated in both addiction and autism spectrum disorders (ASDs); see text for details</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Pathway/Molecule</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Relevance to addiction</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Relevance to ASDs</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Oxytocin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Attenuates behavioral effects of psychostimulant administration (Sarnyai and Kovács, <xref ref-type="bibr" rid="B114">2014</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Social reward involves actions of oxytocin in the nucleus accumbens (Dölen et al., <xref ref-type="bibr" rid="B37">2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine</td>
<td align="left" colspan="1" rowspan="1" valign="top">Important for reward and attribution of incentive salience (Wise, <xref ref-type="bibr" rid="B142">2004</xref>; Berridge, <xref ref-type="bibr" rid="B12">2007</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased release in <italic>Cntnap4</italic> mutant mice (Karayannis et al., <xref ref-type="bibr" rid="B73">2014</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Opioids</td>
<td align="left" colspan="1" rowspan="1" valign="top">Contribute to rewarding effects of exogenous opiates and other drugs (Befort, <xref ref-type="bibr" rid="B10">2015</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism-related behavioral phenotypes in <italic>Oprm1</italic> mutant mice (Moles et al., <xref ref-type="bibr" rid="B90">2004</xref>; Becker et al., <xref ref-type="bibr" rid="B9">2014</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Endocannabinoids</td>
<td align="left" colspan="1" rowspan="1" valign="top">Contribute to drug reward and synaptic plasticity (Befort, <xref ref-type="bibr" rid="B10">2015</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered striatal synaptic plasticity in <italic>Fmr1</italic> and <italic>Eif3e</italic> mutant mice (Jung et al., <xref ref-type="bibr" rid="B72">2012</xref>; Santini et al., <xref ref-type="bibr" rid="B112">2013</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Methyl CpG-Binding Protein-2 (MECP2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered behavioral responses to psychostimulant administration (Deng et al., <xref ref-type="bibr" rid="B33">2010</xref>, <xref ref-type="bibr" rid="B34">2014</xref>; Im et al., <xref ref-type="bibr" rid="B66">2010</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deletions cause Rett syndrome (Amir et al., <xref ref-type="bibr" rid="B4">1999</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fragile X Mental Retardation Protein (FMRP)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered behavioral and synaptic responses to cocaine exposure (Smith et al., <xref ref-type="bibr" rid="B122">2014</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deletions cause fragile X syndrome (Pieretti et al., <xref ref-type="bibr" rid="B103">1991</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec>
<title>Repetitive behavioral patterns as a common dimension of dysfunction</title>
<p>One hallmark of both ASDs and addiction is the repetition of specific patterns of behavior, sometimes in the absence of an obvious goal or even in the face of adverse consequences. Indeed, the transition from casual to compulsive or habitual drug use is one of the defining features of addiction. Conversely, ASDs are associated with behavioral patterns that are performed in a stereotyped fashion and are resistant the change. This can include simple movements like hand flapping, as well as more complex routines and rituals. While somewhat different terminology is used to describe these behavioral patterns (e.g., “compulsive” or “habitual” for addiction, “repetitive” or “stereotyped” for ASDs), all may be characterized by a failure to inhibit the repetition of behavioral patterns. This lack of inhibitory control over repetitive behavior may also contribute to other mental disorders, such as obsessive-compulsive disorder, which is also linked to striatal dysfunction (Burguière et al., <xref ref-type="bibr" rid="B17">2015</xref>).</p>
<p>Rodent models of ASDs and addiction obviously lack the nuance and specificity of the clinical condition, but some interesting similarities in repetitive behavioral patterns seem to suggest common striatal circuitry may be affected in both disorders. For example, stereotyped patterns of rotational behavior caused by ASD-associated genetic mutations (Portmann et al., <xref ref-type="bibr" rid="B104">2014</xref>; Rothwell et al., <xref ref-type="bibr" rid="B109">2014</xref>) are also observed following exposure to psychostimulants (Fowler et al., <xref ref-type="bibr" rid="B47">2001</xref>). Similarly, the orofacial stereotypy caused by repeated exposure to a high dose of cocaine is exacerbated in <italic>Fmr1</italic> knockout mice (Smith et al., <xref ref-type="bibr" rid="B122">2014</xref>). While it is obviously difficult to extrapolate these simple rodent behaviors to the symptoms of complex human disorders likes ASDs and addiction, these examples at least illustrate that some elementary forms of repetitive behavior can be similarly affected by addictive drugs and ASD-associated genetic mutations.</p>
</sec>
<sec>
<title>Aberrant reward processing as a common dimension of dysfunction</title>
<p>The processing of reward-related information represents another behavioral dimension that may be affected in both ASDs and addiction. The concept of reward figures prominently in addiction, where decades of research have led to the identification and dissection of distinct components of reward (reviewed by Berridge et al., <xref ref-type="bibr" rid="B13">2009</xref>). One important distinction is between the hedonic impact or “liking” of reward, and the incentive salience or “wanting” associated with rewards and related environmental stimuli. Repeated drug exposure is thought to selectively exaggerate or sensitize the incentive salience attributed to drugs and drug-related cues, a process that is closely linked to dopamine transmission (for a recent review, see Robinson and Berridge, <xref ref-type="bibr" rid="B107">2008</xref>).</p>
<p>In ASD research, aberrant “reward processing” often refers to altered patterns of brain activity in response to social stimuli or monetary reward (e.g., Scott-Van Zeeland et al., <xref ref-type="bibr" rid="B115">2010</xref>; Delmonte et al., <xref ref-type="bibr" rid="B31">2012</xref>; Dichter et al., <xref ref-type="bibr" rid="B36">2012</xref>; Kohls et al., <xref ref-type="bibr" rid="B74">2013</xref>; Richey et al., <xref ref-type="bibr" rid="B106">2014</xref>). Reduced sensitivity to social stimuli may contribute to the deficits in social behavior associated with ASDs, but the precise nature of this aberrant reward processing remains unclear. For instance, are social deficits in ASDs due to decreased hedonic impact or “liking” of social interaction, or rather to a decrease in the incentive salience or “wanting” associated with social stimuli? An alternative possibility (discussed in more detail below) is that ASDs are associated with indiscriminate attribution of incentive salience to inappropriate stimuli in the environment, which could lead to fixation on these stimuli at the expense of social interaction. Rodents carrying ASD-associated genetic mutations may provide a tractable model to begin disentangling these possibilities, through behavioral assays and direct manipulations of brain function needed to fractionate the different components of reward (Berridge et al., <xref ref-type="bibr" rid="B13">2009</xref>).</p>
</sec>
<sec>
<title>Neural mechanisms for common and distinct dimensions of dysfunction</title>
<p>In light of the putative behavioral dimensions that are commonly impaired in ASDs and addiction, an obvious question arises regarding the elements of striatal circuitry that could commonly contribute to both disorders. One intriguing possibility involves D1-MSNs in the nucleus accumbens, as these cells appear to be a key locus for structural and functional synaptic changes caused by chronic drug exposure (Grueter et al., <xref ref-type="bibr" rid="B55">2012</xref>; Smith et al., <xref ref-type="bibr" rid="B123">2013</xref>). Drug-evoked plasticity at excitatory synapses on D1-MSNs in the nucleus accumbens appears to drive multiple forms of addiction-related behavior (Pascoli et al., <xref ref-type="bibr" rid="B99">2012</xref>, <xref ref-type="bibr" rid="B98">2014</xref>). Furthermore, direct activation of D1-MSNs in the nucleus accumbens enhances both drug reward and the development of psychomotor sensitization (Lobo et al., <xref ref-type="bibr" rid="B85">2010</xref>; Koo et al., <xref ref-type="bibr" rid="B75">2014</xref>), whereas inhibition of these cells reduces the same behavioral effects (Hikida et al., <xref ref-type="bibr" rid="B63">2010</xref>; Ferguson et al., <xref ref-type="bibr" rid="B44">2011</xref>).</p>
<p>Given this established link between addiction and D1-MSNs in the nucleus accumbens, it was both surprising and fascinating that recent reports linked these same cells to social behavior in wild-type mice (Gunaydin et al., <xref ref-type="bibr" rid="B56">2014</xref>), as well as repetitive behavior in mice carrying ASD-associated mutations in <italic>Nlgn3</italic> (Rothwell et al., <xref ref-type="bibr" rid="B109">2014</xref>). The former study suggests dopamine release and activation of D1-MSNs are both important for the expression of social behavior in mice (Gunaydin et al., <xref ref-type="bibr" rid="B56">2014</xref>), whereas the latter study suggests synaptic disinhibition of D1-MSNs leads to repetitive behavior (Rothwell et al., <xref ref-type="bibr" rid="B109">2014</xref>). These two patterns of results may appear contradictory in relation to ASDs, which are associated with less social behavior and more repetitive behavior. One potential explanation for this apparent contradiction (considered below) also provides insight into how the altered activity of one cell type could lead to both common and distinct dimensions of dysfunction.</p>
<p>Continuous synaptic disinhibition of D1-MSNs may lead to chronic elevation of baseline activity in these cells, thereby occluding phasic increases in activity that encode normal social behavior. Chronic elevation of baseline activity in D1-MSNs may also influence dopamine levels in the striatum, as axonal projections from these cells to the ventral tegmental area appear to synapse preferentially onto interneurons, which in turn inhibit dopamine neurons (Xia et al., <xref ref-type="bibr" rid="B143">2011</xref>; Bocklisch et al., <xref ref-type="bibr" rid="B15">2013</xref>). Disinhibition of D1-MSNs may therefore translate into disinhibition of dopamine neurons and increase dopamine release in the back into the striatum. This continuous increase in dopamine release would resemble the effects of ASD-associated genetic mutations in <italic>Cntnap4</italic> (Karayannis et al., <xref ref-type="bibr" rid="B73">2014</xref>), and could lead to indiscriminate attribution of incentive salience to inappropriate stimuli in the environment. This “non-specific” attribution of incentive salience would be fundamentally different from the attribution of incentive salience in addiction, which is excessively large in magnitude but still specifically attributed to drugs and drug-related cues. Thus, increased activation of D1-MSNs and excessive dopamine release may be a common feature of ASDs and addiction, but there may be differences in how this cellular change is manifested in the clinical features of each disorder.</p>
<p>It is also becoming increasingly apparent that D1-MSNs in the nucleus accumbens exhibit heterogeneity in terms of function, structure, and neurochemistry. D1-MSNs specifically co-express the neuropeptide dynorphin, and activation of dynorphinergic cells in different subregions of the nucleus accumbens can lead to opposite behavioral effects (Al-Hasani et al., <xref ref-type="bibr" rid="B2">2015</xref>). D1-MSNs in the nucleus accumbens also send axonal projections to both the ventral mesencephalon and ventral pallidum, and therefore contribute to both the direct and indirect pathways through the basal ganglia (Kupchik et al., <xref ref-type="bibr" rid="B77">2015</xref>). Furthermore, a small population of MSNs in the nucleus accumbens appears to express both D1 and D2 dopamine receptor subtypes (Perreault et al., <xref ref-type="bibr" rid="B102">2011</xref>). Subtle differences in how ASDs and addiction impact different subpopulations of D1-MSNs could also contribute to distinct clinical manifestations of these disorders.</p>
</sec>
<sec>
<title>Therapeutic implications</title>
<p>Parallel dissection of striatal circuitry in ASDs and addiction may enable therapeutic advances in one field to inform progress in the other. For example, in the realm of addiction, the key role for D1-MSNs in promoting the behavioral effects of cocaine recently inspired an intersectional approach to reversing cocaine-evoked synaptic plasticity in mice, through the combination of deep brain stimulation of the nucleus accumbens and a pharmacological manipulation that selectively targets D1-MSNs (Creed et al., <xref ref-type="bibr" rid="B28">2015</xref>). This type of intersectional strategy may prove beneficial as deep brain stimulation and other forms of neuromodulation are developed for clinical treatment of patients with ASDs (Sturm et al., <xref ref-type="bibr" rid="B126">2012</xref>; Enticott et al., <xref ref-type="bibr" rid="B40">2014</xref>; Sinha et al., <xref ref-type="bibr" rid="B121">2015</xref>). Other types of intersectional therapeutic strategies could involve simultaneous manipulation of multiple neuromodulatory systems that intersect in the nucleus accumbens, such as oxytocin and serotonin (Dölen et al., <xref ref-type="bibr" rid="B37">2013</xref>), or opioids and cannabinoids (Befort, <xref ref-type="bibr" rid="B10">2015</xref>). The opioid and cannabinoid systems may be particularly tractable therapeutic targets, given their rich and diverse pharmacology as well as active drug development efforts for treatment of pain.</p>
<p>ASDs and drug addiction are complicated disorders that likely involve many parts of the brain, but the literature reviewed here highlights a central role for the striatum and basal ganglia in both disorders. In the striatum, these disorders impact a variety of neuromodulatory systems converging on multiple postsynaptic cells types. This intrinsic complexity makes it challenging to study striatal circuits in the context of disease, but also increases the number of potential therapeutic targets as well as the possibility of developing interventions that specifically affect individual circuit elements. It is quite likely that some common elements of this circuitry (like D1-MSNs in the nucleus accumbens) contribute to the pathophysiology of both ASDs and addiction, while other elements within or beyond the striatum are uniquely involved in only one disorder. A growing knowledge of both common and distinct dimensions of dysfunction will help guide the development of interventions that could be broadly useful for normalizing neural circuit dysfunction that contributes to behavioral deficits in both ASDs and addiction.</p>
</sec>
</sec>
<sec id="s5">
<title>Author contributions</title>
<p>The author confirms being the sole contributor of this work and approved it for publication.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>Preparation of this article was supported by grant K99DA037279 from the U.S. National Institutes of Health.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname><given-names>D. A.</given-names></name><name><surname>Lynch</surname><given-names>C. J.</given-names></name><name><surname>Cheng</surname><given-names>K. M.</given-names></name><name><surname>Phillips</surname><given-names>J.</given-names></name><name><surname>Supekar</surname><given-names>K.</given-names></name><name><surname>Ryali</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Underconnectivity between voice-selective cortex and reward circuitry in children with autism</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>110</volume>, <fpage>12060</fpage>–<lpage>12065</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1302982110</pub-id><pub-id pub-id-type="pmid">23776244</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Hasani</surname><given-names>R.</given-names></name><name><surname>McCall</surname><given-names>J. G.</given-names></name><name><surname>Shin</surname><given-names>G.</given-names></name><name><surname>Gomez</surname><given-names>A. M.</given-names></name><name><surname>Schmitz</surname><given-names>G. P.</given-names></name><name><surname>Bernardi</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward</article-title>. <source/>Neuron
<volume>87</volume>, <fpage>1063</fpage>–<lpage>1077</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.08.019</pub-id><pub-id pub-id-type="pmid">26335648</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albin</surname><given-names>R. L.</given-names></name><name><surname>Young</surname><given-names>A. B.</given-names></name><name><surname>Penney</surname><given-names>J. B.</given-names></name></person-group> (<year>1989</year>). <article-title>The functional anatomy of basal ganglia disorders</article-title>. <source/>Trends Neurosci.
<volume>12</volume>, <fpage>366</fpage>–<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1016/0166-2236(89)90074-X</pub-id><pub-id pub-id-type="pmid">2479133</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>R. E.</given-names></name><name><surname>Van Den Veyver</surname><given-names>I. B.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Tran</surname><given-names>C. Q.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>. <source/>Nat. Genet.
<volume>23</volume>, <fpage>185</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/13810</pub-id><pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anacker</surname><given-names>A. M.</given-names></name><name><surname>Beery</surname><given-names>A. K.</given-names></name></person-group> (<year>2013</year>). <article-title>Life in groups: the roles of oxytocin in mammalian sociality</article-title>. <source/>Front. Behav. Neurosci.
<volume>7</volume>:<issue>185</issue>. <pub-id pub-id-type="doi">10.3389/fnbeh.2013.00185</pub-id><pub-id pub-id-type="pmid">24376404</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbach</surname><given-names>B. D.</given-names></name><name><surname>Osterweil</surname><given-names>E. K.</given-names></name><name><surname>Bear</surname><given-names>M. F.</given-names></name></person-group> (<year>2011</year>). <article-title>Mutations causing syndromic autism define an axis of synaptic pathophysiology</article-title>. <source/>Nature
<volume>480</volume>, <fpage>63</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/nature10658</pub-id><pub-id pub-id-type="pmid">22113615</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balleine</surname><given-names>B. W.</given-names></name><name><surname>Delgado</surname><given-names>M. R.</given-names></name><name><surname>Hikosaka</surname><given-names>O.</given-names></name></person-group> (<year>2007</year>). <article-title>The role of the dorsal striatum in reward and decision-making</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>8161</fpage>–<lpage>8165</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1554-07.2007</pub-id><pub-id pub-id-type="pmid">17670959</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balleine</surname><given-names>B. W.</given-names></name><name><surname>O'Doherty</surname><given-names>J. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action</article-title>. <source/>Neuropsychopharmacology
<volume>35</volume>, <fpage>48</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2009.131</pub-id><pub-id pub-id-type="pmid">19776734</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>J. A.</given-names></name><name><surname>Clesse</surname><given-names>D.</given-names></name><name><surname>Spiegelhalter</surname><given-names>C.</given-names></name><name><surname>Schwab</surname><given-names>Y.</given-names></name><name><surname>Le Merrer</surname><given-names>J.</given-names></name><name><surname>Kieffer</surname><given-names>B. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity</article-title>. <source/>Neuropsychopharmacology
<volume>39</volume>, <fpage>2049</fpage>–<lpage>2060</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2014.59</pub-id><pub-id pub-id-type="pmid">24619243</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Befort</surname><given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>Interactions of the opioid and cannabinoid systems in reward: insights from knockout studies</article-title>. <source/>Front. Pharmacol.
<volume>6</volume>:<issue>6</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2015.00006</pub-id><pub-id pub-id-type="pmid">25698968</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belin</surname><given-names>D.</given-names></name><name><surname>Everitt</surname><given-names>B. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum</article-title>. <source/>Neuron
<volume>57</volume>, <fpage>432</fpage>–<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.12.019</pub-id><pub-id pub-id-type="pmid">18255035</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>K. C.</given-names></name></person-group> (<year>2007</year>). <article-title>The debate over dopamine's role in reward: the case for incentive salience</article-title>. <source/>Psychopharmacology (Berl.)
<volume>191</volume>, <fpage>391</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-006-0578-x</pub-id><pub-id pub-id-type="pmid">17072591</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>K. C.</given-names></name><name><surname>Robinson</surname><given-names>T. E.</given-names></name><name><surname>Aldridge</surname><given-names>J. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Dissecting components of reward: ‘liking’, ‘wanting’, and learning</article-title>. <source/>Curr. Opin. Pharmacol.
<volume>9</volume>, <fpage>65</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2008.12.014</pub-id><pub-id pub-id-type="pmid">19162544</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bock</surname><given-names>R.</given-names></name><name><surname>Shin</surname><given-names>J. H.</given-names></name><name><surname>Kaplan</surname><given-names>A. R.</given-names></name><name><surname>Dobi</surname><given-names>A.</given-names></name><name><surname>Markey</surname><given-names>E.</given-names></name><name><surname>Kramer</surname><given-names>P. F.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Strengthening the accumbal indirect pathway promotes resilience to compulsive cocaine use</article-title>. <source/>Nat. Neurosci.
<volume>16</volume>, <fpage>632</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3369</pub-id><pub-id pub-id-type="pmid">23542690</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bocklisch</surname><given-names>C.</given-names></name><name><surname>Pascoli</surname><given-names>V.</given-names></name><name><surname>Wong</surname><given-names>J. C.</given-names></name><name><surname>House</surname><given-names>D. R.</given-names></name><name><surname>Yvon</surname><given-names>C.</given-names></name><name><surname>De Roo</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area</article-title>. <source/>Science
<volume>341</volume>, <fpage>1521</fpage>–<lpage>1525</lpage>. <pub-id pub-id-type="doi">10.1126/science.1237059</pub-id><pub-id pub-id-type="pmid">24072923</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowton</surname><given-names>E.</given-names></name><name><surname>Saunders</surname><given-names>C.</given-names></name><name><surname>Reddy</surname><given-names>I. A.</given-names></name><name><surname>Campbell</surname><given-names>N. G.</given-names></name><name><surname>Hamilton</surname><given-names>P. J.</given-names></name><name><surname>Henry</surname><given-names>L. K.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking</article-title>. <source/>Transl. Psychiatry
<volume>4</volume>, <fpage>e464</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2014.90</pub-id><pub-id pub-id-type="pmid">25313507</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burguière</surname><given-names>E.</given-names></name><name><surname>Monteiro</surname><given-names>P.</given-names></name><name><surname>Mallet</surname><given-names>L.</given-names></name><name><surname>Feng</surname><given-names>G.</given-names></name><name><surname>Graybiel</surname><given-names>A. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Striatal circuits, habits, and implications for obsessive-compulsive disorder</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>30</volume>, <fpage>59</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2014.08.008</pub-id><pub-id pub-id-type="pmid">25241072</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkett</surname><given-names>J. P.</given-names></name><name><surname>Spiegel</surname><given-names>L. L.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><name><surname>Murphy</surname><given-names>A. Z.</given-names></name><name><surname>Young</surname><given-names>L. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Activation of mu-opioid receptors in the dorsal striatum is necessary for adult social attachment in monogamous prairie voles</article-title>. <source/>Neuropsychopharmacology
<volume>36</volume>, <fpage>2200</fpage>–<lpage>2210</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2011.117</pub-id><pub-id pub-id-type="pmid">21734650</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkett</surname><given-names>J. P.</given-names></name><name><surname>Young</surname><given-names>L. J.</given-names></name></person-group> (<year>2012</year>). <article-title>The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction</article-title>. <source/>Psychopharmacology (Berl.)
<volume>224</volume>, <fpage>1</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-012-2794-x</pub-id><pub-id pub-id-type="pmid">22885871</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkett</surname><given-names>Z. D.</given-names></name><name><surname>Day</surname><given-names>N. F.</given-names></name><name><surname>Peñagarikano</surname><given-names>O.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name><name><surname>White</surname><given-names>S. A.</given-names></name></person-group> (<year>2015</year>). <article-title>VoICE: a semi-automated pipeline for standardizing vocal analysis across models</article-title>. <source/>Sci. Rep.
<volume>5</volume>, <fpage>10237</fpage>. <pub-id pub-id-type="doi">10.1038/srep10237</pub-id><pub-id pub-id-type="pmid">26018425</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlezon</surname><given-names>W. A.</given-names><suffix>Jr.</suffix></name><name><surname>Thomas</surname><given-names>M. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis</article-title>. <source/>Neuropharmacology
<volume>56</volume>(<issue>Suppl. 1</issue>), <fpage>122</fpage>–<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.06.075</pub-id><pub-id pub-id-type="pmid">18675281</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carp</surname><given-names>S. B.</given-names></name><name><surname>Rothwell</surname><given-names>E. S.</given-names></name><name><surname>Bourdon</surname><given-names>A.</given-names></name><name><surname>Freeman</surname><given-names>S. M.</given-names></name><name><surname>Ferrer</surname><given-names>E.</given-names></name><name><surname>Bales</surname><given-names>K. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Development of a partner preference test that differentiates between established pair bonds and other relationships in socially monogamous titi monkeys (<italic>Callicebus cupreus</italic>)</article-title>. <source/>Am. J. Primatol. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1002/ajp.22450</pub-id><pub-id pub-id-type="pmid">26235811</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>C. S.</given-names></name><name><surname>Devries</surname><given-names>A. C.</given-names></name><name><surname>Getz</surname><given-names>L. L.</given-names></name></person-group> (<year>1995</year>). <article-title>Physiological substrates of mammalian monogamy: the prairie vole model</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>19</volume>, <fpage>303</fpage>–<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1016/0149-7634(94)00070-H</pub-id><pub-id pub-id-type="pmid">7630584</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Centonze</surname><given-names>D.</given-names></name><name><surname>Rossi</surname><given-names>S.</given-names></name><name><surname>Mercaldo</surname><given-names>V.</given-names></name><name><surname>Napoli</surname><given-names>I.</given-names></name><name><surname>Ciotti</surname><given-names>M. T.</given-names></name><name><surname>De Chiara</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome</article-title>. <source/>Biol. Psychiatry
<volume>63</volume>, <fpage>963</fpage>–<lpage>973</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2007.09.008</pub-id><pub-id pub-id-type="pmid">18028882</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>J.</given-names></name><name><surname>Gilman</surname><given-names>S. R.</given-names></name><name><surname>Chiang</surname><given-names>A. H.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Vitkup</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Genotype to phenotype relationships in autism spectrum disorders</article-title>. <source/>Nat. Neurosci.
<volume>18</volume>, <fpage>191</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3907</pub-id><pub-id pub-id-type="pmid">25531569</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J. A.</given-names></name><name><surname>Peñagarikano</surname><given-names>O.</given-names></name><name><surname>Belgard</surname><given-names>T. G.</given-names></name><name><surname>Swarup</surname><given-names>V.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name></person-group> (<year>2015</year>). <article-title>The emerging picture of autism spectrum disorder: genetics and pathology</article-title>. <source/>Annu. Rev. Pathol.
<volume>10</volume>, <fpage>111</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pathol-012414-040405</pub-id><pub-id pub-id-type="pmid">25621659</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comings</surname><given-names>D. E.</given-names></name><name><surname>Comings</surname><given-names>B. G.</given-names></name><name><surname>Muhleman</surname><given-names>D.</given-names></name><name><surname>Dietz</surname><given-names>G.</given-names></name><name><surname>Shahbahrami</surname><given-names>B.</given-names></name><name><surname>Tast</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders</article-title>. <source/>JAMA
<volume>266</volume>, <fpage>1793</fpage>–<lpage>1800</lpage>. <pub-id pub-id-type="doi">10.1001/jama.1991.03470130073032</pub-id><pub-id pub-id-type="pmid">1832466</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Creed</surname><given-names>M.</given-names></name><name><surname>Pascoli</surname><given-names>V. J.</given-names></name><name><surname>Luscher</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Addiction therapy. Refining deep brain stimulation to emulate optogenetic treatment of synaptic pathology</article-title>. <source/>Science
<volume>347</volume>, <fpage>659</fpage>–<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1126/science.1260776</pub-id><pub-id pub-id-type="pmid">25657248</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname><given-names>J. T.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Aragona</surname><given-names>B. J.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group> (<year>2006</year>). <article-title>Dopamine and monogamy</article-title>. <source/>Brain Res.
<volume>1126</volume>, <fpage>76</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2006.07.126</pub-id><pub-id pub-id-type="pmid">16950234</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Krom</surname><given-names>M.</given-names></name><name><surname>Staal</surname><given-names>W. G.</given-names></name><name><surname>Ophoff</surname><given-names>R. A.</given-names></name><name><surname>Hendriks</surname><given-names>J.</given-names></name><name><surname>Buitelaar</surname><given-names>J.</given-names></name><name><surname>Franke</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>A common variant in DRD3 receptor is associated with autism spectrum disorder</article-title>. <source/>Biol. Psychiatry
<volume>65</volume>, <fpage>625</fpage>–<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2008.09.035</pub-id><pub-id pub-id-type="pmid">19058789</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delmonte</surname><given-names>S.</given-names></name><name><surname>Balsters</surname><given-names>J. H.</given-names></name><name><surname>McGrath</surname><given-names>J.</given-names></name><name><surname>Fitzgerald</surname><given-names>J.</given-names></name><name><surname>Brennan</surname><given-names>S.</given-names></name><name><surname>Fagan</surname><given-names>A. J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Social and monetary reward processing in autism spectrum disorders</article-title>. <source/>Mol. Autism
<volume>3</volume>, <fpage>7</fpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-3-7</pub-id><pub-id pub-id-type="pmid">23014171</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLong</surname><given-names>M. R.</given-names></name></person-group> (<year>1990</year>). <article-title>Primate models of movement disorders of basal ganglia origin</article-title>. <source/>Trends Neurosci.
<volume>13</volume>, <fpage>281</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1016/0166-2236(90)90110-V</pub-id><pub-id pub-id-type="pmid">1695404</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>J. V.</given-names></name><name><surname>Rodriguiz</surname><given-names>R. M.</given-names></name><name><surname>Hutchinson</surname><given-names>A. N.</given-names></name><name><surname>Kim</surname><given-names>I. H.</given-names></name><name><surname>Wetsel</surname><given-names>W. C.</given-names></name><name><surname>West</surname><given-names>A. E.</given-names></name></person-group> (<year>2010</year>). <article-title>MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants</article-title>. <source/>Nat. Neurosci.
<volume>13</volume>, <fpage>1128</fpage>–<lpage>1136</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2614</pub-id><pub-id pub-id-type="pmid">20711186</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>J. V.</given-names></name><name><surname>Wan</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Cohen</surname><given-names>S.</given-names></name><name><surname>Wetsel</surname><given-names>W. C.</given-names></name><name><surname>Greenberg</surname><given-names>M. E.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>MeCP2 phosphorylation limits psychostimulant-induced behavioral and neuronal plasticity</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>4519</fpage>–<lpage>4527</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2821-13.2014</pub-id><pub-id pub-id-type="pmid">24671997</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Martino</surname><given-names>A.</given-names></name><name><surname>Kelly</surname><given-names>C.</given-names></name><name><surname>Grzadzinski</surname><given-names>R.</given-names></name><name><surname>Zuo</surname><given-names>X. N.</given-names></name><name><surname>Mennes</surname><given-names>M.</given-names></name><name><surname>Mairena</surname><given-names>M. A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Aberrant striatal functional connectivity in children with autism</article-title>. <source/>Biol. Psychiatry
<volume>69</volume>, <fpage>847</fpage>–<lpage>856</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.10.029</pub-id><pub-id pub-id-type="pmid">21195388</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dichter</surname><given-names>G. S.</given-names></name><name><surname>Felder</surname><given-names>J. N.</given-names></name><name><surname>Green</surname><given-names>S. R.</given-names></name><name><surname>Rittenberg</surname><given-names>A. M.</given-names></name><name><surname>Sasson</surname><given-names>N. J.</given-names></name><name><surname>Bodfish</surname><given-names>J. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Reward circuitry function in autism spectrum disorders</article-title>. <source/>Soc. Cogn. Affect. Neurosci.
<volume>7</volume>, <fpage>160</fpage>–<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1093/scan/nsq095</pub-id><pub-id pub-id-type="pmid">21148176</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dölen</surname><given-names>G.</given-names></name><name><surname>Darvishzadeh</surname><given-names>A.</given-names></name><name><surname>Huang</surname><given-names>K. W.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin</article-title>. <source/>Nature
<volume>501</volume>, <fpage>179</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1038/nature12518</pub-id><pub-id pub-id-type="pmid">24025838</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durieux</surname><given-names>P. F.</given-names></name><name><surname>Bearzatto</surname><given-names>B.</given-names></name><name><surname>Guiducci</surname><given-names>S.</given-names></name><name><surname>Buch</surname><given-names>T.</given-names></name><name><surname>Waisman</surname><given-names>A.</given-names></name><name><surname>Zoli</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>D2R striatopallidal neurons inhibit both locomotor and drug reward processes</article-title>. <source/>Nat. Neurosci.
<volume>12</volume>, <fpage>393</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2286</pub-id><pub-id pub-id-type="pmid">19270687</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eliez</surname><given-names>S.</given-names></name><name><surname>Blasey</surname><given-names>C. M.</given-names></name><name><surname>Freund</surname><given-names>L. S.</given-names></name><name><surname>Hastie</surname><given-names>T.</given-names></name><name><surname>Reiss</surname><given-names>A. L.</given-names></name></person-group> (<year>2001</year>). <article-title>Brain anatomy, gender and IQ in children and adolescents with fragile X syndrome</article-title>. <source/>Brain
<volume>124</volume>, <fpage>1610</fpage>–<lpage>1618</lpage>. <pub-id pub-id-type="doi">10.1093/brain/124.8.1610</pub-id><pub-id pub-id-type="pmid">11459752</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enticott</surname><given-names>P. G.</given-names></name><name><surname>Fitzgibbon</surname><given-names>B. M.</given-names></name><name><surname>Kennedy</surname><given-names>H. A.</given-names></name><name><surname>Arnold</surname><given-names>S. L.</given-names></name><name><surname>Elliot</surname><given-names>D.</given-names></name><name><surname>Peachey</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>A double-blind, randomized trial of deep repetitive transcranial magnetic stimulation (rTMS) for autism spectrum disorder</article-title>. <source/>Brain Stimul.
<volume>7</volume>, <fpage>206</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1016/j.brs.2013.10.004</pub-id><pub-id pub-id-type="pmid">24280031</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etherton</surname><given-names>M.</given-names></name><name><surname>Földy</surname><given-names>C.</given-names></name><name><surname>Sharma</surname><given-names>M.</given-names></name><name><surname>Tabuchi</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Shamloo</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>108</volume>, <fpage>13764</fpage>–<lpage>13769</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1111093108</pub-id><pub-id pub-id-type="pmid">21808020</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etherton</surname><given-names>M. R.</given-names></name><name><surname>Blaiss</surname><given-names>C. A.</given-names></name><name><surname>Powell</surname><given-names>C. M.</given-names></name><name><surname>Sudhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>106</volume>, <fpage>17998</fpage>–<lpage>18003</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0910297106</pub-id><pub-id pub-id-type="pmid">19822762</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everitt</surname><given-names>B. J.</given-names></name><name><surname>Robbins</surname><given-names>T. W.</given-names></name></person-group> (<year>2016</year>). <article-title>Drug addiction: updating actions to habits to compulsions ten years on</article-title>. <source/>Annu. Rev. Psychol. <volume>67</volume>, <fpage>23</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-psych-122414-033457</pub-id><pub-id pub-id-type="pmid">26253543</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>S. M.</given-names></name><name><surname>Eskenazi</surname><given-names>D.</given-names></name><name><surname>Ishikawa</surname><given-names>M.</given-names></name><name><surname>Wanat</surname><given-names>M. J.</given-names></name><name><surname>Phillips</surname><given-names>P. E.</given-names></name><name><surname>Dong</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization</article-title>. <source/>Nat. Neurosci.
<volume>14</volume>, <fpage>22</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2703</pub-id><pub-id pub-id-type="pmid">21131952</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Földy</surname><given-names>C.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name><name><surname>Sudhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling</article-title>. <source/>Neuron
<volume>78</volume>, <fpage>498</fpage>–<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.02.036</pub-id><pub-id pub-id-type="pmid">23583622</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fourgeaud</surname><given-names>L.</given-names></name><name><surname>Mato</surname><given-names>S.</given-names></name><name><surname>Bouchet</surname><given-names>D.</given-names></name><name><surname>Hémar</surname><given-names>A.</given-names></name><name><surname>Worley</surname><given-names>P. F.</given-names></name><name><surname>Manzoni</surname><given-names>O. J.</given-names></name></person-group> (<year>2004</year>). <article-title>A single <italic>in vivo</italic> exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>6939</fpage>–<lpage>6945</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0671-04.2004</pub-id><pub-id pub-id-type="pmid">15295029</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fowler</surname><given-names>S. C.</given-names></name><name><surname>Birkestrand</surname><given-names>B. R.</given-names></name><name><surname>Chen</surname><given-names>R.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Vorontsova</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor</article-title>. <source/>J. Neurosci. Methods
<volume>107</volume>, <fpage>107</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-0270(01)00359-4</pub-id><pub-id pub-id-type="pmid">11389948</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuccillo</surname><given-names>M. V.</given-names></name><name><surname>Rothwell</surname><given-names>P. E.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name></person-group> (<year>2016</year>). <article-title>From synapses to behavior: what rodent models can tell us about neuropsychiatric disease</article-title>. <source/>Biol. Psychiatry
<volume>79</volume>, <fpage>4</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.02.009</pub-id><pub-id pub-id-type="pmid">26616432</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerfen</surname><given-names>C. R.</given-names></name><name><surname>Surmeier</surname><given-names>D. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Modulation of striatal projection systems by dopamine</article-title>. <source/>Annu. Rev. Neurosci.
<volume>34</volume>, <fpage>441</fpage>–<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-061010-113641</pub-id><pub-id pub-id-type="pmid">21469956</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gigliucci</surname><given-names>V.</given-names></name><name><surname>Leonzino</surname><given-names>M.</given-names></name><name><surname>Busnelli</surname><given-names>M.</given-names></name><name><surname>Luchetti</surname><given-names>A.</given-names></name><name><surname>Palladino</surname><given-names>V. S.</given-names></name><name><surname>D'Amato</surname><given-names>F. R.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Region specific up-regulation of oxytocin receptors in the opioid oprm1 (-/-) mouse model of autism</article-title>. <source/>Front. Pediatr.
<volume>2</volume>:<fpage>91</fpage>. <pub-id pub-id-type="doi">10.3389/fped.2014.00091</pub-id><pub-id pub-id-type="pmid">25225634</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>S.</given-names></name><name><surname>Doughty</surname><given-names>M.</given-names></name><name><surname>Harbaugh</surname><given-names>C. R.</given-names></name><name><surname>Cummins</surname><given-names>A.</given-names></name><name><surname>Hatten</surname><given-names>M. E.</given-names></name><name><surname>Heintz</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>9817</fpage>–<lpage>9823</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2707-07.2007</pub-id><pub-id pub-id-type="pmid">17855595</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>S.</given-names></name><name><surname>Zheng</surname><given-names>C.</given-names></name><name><surname>Doughty</surname><given-names>M. L.</given-names></name><name><surname>Losos</surname><given-names>K.</given-names></name><name><surname>Didkovsky</surname><given-names>N.</given-names></name><name><surname>Schambra</surname><given-names>U. B.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>A gene expression atlas of the central nervous system based on bacterial artificial chromosomes</article-title>. <source/>Nature
<volume>425</volume>, <fpage>917</fpage>–<lpage>925</lpage>. <pub-id pub-id-type="doi">10.1038/nature02033</pub-id><pub-id pub-id-type="pmid">14586460</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graybiel</surname><given-names>A. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Habits, rituals, and the evaluative brain</article-title>. <source/>Annu. Rev. Neurosci.
<volume>31</volume>, <fpage>359</fpage>–<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.29.051605.112851</pub-id><pub-id pub-id-type="pmid">18558860</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grueter</surname><given-names>B. A.</given-names></name><name><surname>Brasnjo</surname><given-names>G.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens</article-title>. <source/>Nat. Neurosci.
<volume>13</volume>, <fpage>1519</fpage>–<lpage>1525</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2685</pub-id><pub-id pub-id-type="pmid">21076424</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grueter</surname><given-names>B. A.</given-names></name><name><surname>Rothwell</surname><given-names>P. E.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Integrating synaptic plasticity and striatal circuit function in addiction</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>22</volume>, <fpage>545</fpage>–<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2011.09.009</pub-id><pub-id pub-id-type="pmid">22000687</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunaydin</surname><given-names>L. A.</given-names></name><name><surname>Grosenick</surname><given-names>L.</given-names></name><name><surname>Finkelstein</surname><given-names>J. C.</given-names></name><name><surname>Kauvar</surname><given-names>I. V.</given-names></name><name><surname>Fenno</surname><given-names>L. E.</given-names></name><name><surname>Adhikari</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Natural neural projection dynamics underlying social behavior</article-title>. <source/>Cell
<volume>157</volume>, <fpage>1535</fpage>–<lpage>1551</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.05.017</pub-id><pub-id pub-id-type="pmid">24949967</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haber</surname><given-names>S. N.</given-names></name><name><surname>Fudge</surname><given-names>J. L.</given-names></name><name><surname>McFarland</surname><given-names>N. R.</given-names></name></person-group> (<year>2000</year>). <article-title>Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum</article-title>. <source/>J. Neurosci.
<volume>20</volume>, <fpage>2369</fpage>–<lpage>2382</lpage>. <pub-id pub-id-type="pmid">10704511</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>P. J.</given-names></name><name><surname>Campbell</surname><given-names>N. G.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Erreger</surname><given-names>K.</given-names></name><name><surname>Herborg Hansen</surname><given-names>F.</given-names></name><name><surname>Saunders</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title><italic>De novo</italic> mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder</article-title>. <source/>Mol. Psychiatry
<volume>18</volume>, <fpage>1315</fpage>–<lpage>1323</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.102</pub-id><pub-id pub-id-type="pmid">23979605</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haznedar</surname><given-names>M. M.</given-names></name><name><surname>Buchsbaum</surname><given-names>M. S.</given-names></name><name><surname>Hazlett</surname><given-names>E. A.</given-names></name><name><surname>Licalzi</surname><given-names>E. M.</given-names></name><name><surname>Cartwright</surname><given-names>C.</given-names></name><name><surname>Hollander</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders</article-title>. <source/>Am. J. Psychiatry
<volume>163</volume>, <fpage>1252</fpage>–<lpage>1263</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.2006.163.7.1252</pub-id><pub-id pub-id-type="pmid">16816232</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heintz</surname><given-names>N.</given-names></name></person-group> (<year>2001</year>). <article-title>BAC to the future: the use of bac transgenic mice for neuroscience research</article-title>. <source/>Nat. Rev. Neurosci.
<volume>2</volume>, <fpage>861</fpage>–<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1038/35104049</pub-id><pub-id pub-id-type="pmid">11733793</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hettinger</surname><given-names>J. A.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Hudson</surname><given-names>M. L.</given-names></name><name><surname>Lee</surname><given-names>A.</given-names></name><name><surname>Cohen</surname><given-names>I. L.</given-names></name><name><surname>Michaelis</surname><given-names>R. C.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>DRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families</article-title>. <source/>Behav. Brain Funct.
<volume>8</volume>, <fpage>19</fpage>. <pub-id pub-id-type="doi">10.1186/1744-9081-8-19</pub-id><pub-id pub-id-type="pmid">22559203</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hettinger</surname><given-names>J. A.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Schwartz</surname><given-names>C. E.</given-names></name><name><surname>Michaelis</surname><given-names>R. C.</given-names></name><name><surname>Holden</surname><given-names>J. J.</given-names></name></person-group> (<year>2008</year>). <article-title>A DRD1 haplotype is associated with risk for autism spectrum disorders in male-only affected sib-pair families</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>147B</volume>, <fpage>628</fpage>–<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30655</pub-id><pub-id pub-id-type="pmid">18205172</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hikida</surname><given-names>T.</given-names></name><name><surname>Kimura</surname><given-names>K.</given-names></name><name><surname>Wada</surname><given-names>N.</given-names></name><name><surname>Funabiki</surname><given-names>K.</given-names></name><name><surname>Nakanishi</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior</article-title>. <source/>Neuron
<volume>66</volume>, <fpage>896</fpage>–<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.05.011</pub-id><pub-id pub-id-type="pmid">20620875</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollander</surname><given-names>E.</given-names></name><name><surname>Anagnostou</surname><given-names>E.</given-names></name><name><surname>Chaplin</surname><given-names>W.</given-names></name><name><surname>Esposito</surname><given-names>K.</given-names></name><name><surname>Haznedar</surname><given-names>M. M.</given-names></name><name><surname>Licalzi</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Striatal volume on magnetic resonance imaging and repetitive behaviors in autism</article-title>. <source/>Biol. Psychiatry
<volume>58</volume>, <fpage>226</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2005.03.040</pub-id><pub-id pub-id-type="pmid">15939406</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikemoto</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex</article-title>. <source/>Brain Res. Rev.
<volume>56</volume>, <fpage>27</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresrev.2007.05.004</pub-id><pub-id pub-id-type="pmid">17574681</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>H. I.</given-names></name><name><surname>Hollander</surname><given-names>J. A.</given-names></name><name><surname>Bali</surname><given-names>P.</given-names></name><name><surname>Kenny</surname><given-names>P. J.</given-names></name></person-group> (<year>2010</year>). <article-title>MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212</article-title>. <source/>Nat. Neurosci.
<volume>13</volume>, <fpage>1120</fpage>–<lpage>1127</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2615</pub-id><pub-id pub-id-type="pmid">20711185</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>T.</given-names></name><name><surname>Cuthbert</surname><given-names>B.</given-names></name><name><surname>Garvey</surname><given-names>M.</given-names></name><name><surname>Heinssen</surname><given-names>R.</given-names></name><name><surname>Pine</surname><given-names>D. S.</given-names></name><name><surname>Quinn</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Research domain criteria (RDoC): toward a new classification framework for research on mental disorders</article-title>. <source/>Am. J. Psychiatry
<volume>167</volume>, <fpage>748</fpage>–<lpage>751</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2010.09091379</pub-id><pub-id pub-id-type="pmid">20595427</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>T. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Is social attachment an addictive disorder?</article-title>
<source/>Physiol. Behav.
<volume>79</volume>, <fpage>351</fpage>–<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1016/S0031-9384(03)00148-3</pub-id><pub-id pub-id-type="pmid">12954430</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>T. R.</given-names></name><name><surname>Cuthbert</surname><given-names>B. N.</given-names></name></person-group> (<year>2015</year>). <article-title>Medicine. Brain disorders? Precisely</article-title>. <source/>Science
<volume>348</volume>, <fpage>499</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1126/science.aab2358</pub-id><pub-id pub-id-type="pmid">25931539</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>T. R.</given-names></name><name><surname>Young</surname><given-names>L. J.</given-names></name></person-group> (<year>2001</year>). <article-title>The neurobiology of attachment</article-title>. <source/>Nat. Rev. Neurosci.
<volume>2</volume>, <fpage>129</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1038/35053579</pub-id><pub-id pub-id-type="pmid">11252992</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y. H.</given-names></name><name><surname>Ehlers</surname><given-names>M. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Modeling autism by SHANK gene mutations in mice</article-title>. <source/>Neuron
<volume>78</volume>, <fpage>8</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.016</pub-id><pub-id pub-id-type="pmid">23583105</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>K. M.</given-names></name><name><surname>Sepers</surname><given-names>M.</given-names></name><name><surname>Henstridge</surname><given-names>C. M.</given-names></name><name><surname>Lassalle</surname><given-names>O.</given-names></name><name><surname>Neuhofer</surname><given-names>D.</given-names></name><name><surname>Martin</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome</article-title>. <source/>Nat. Commun.
<volume>3</volume>, <fpage>1080</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms2045</pub-id><pub-id pub-id-type="pmid">23011134</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karayannis</surname><given-names>T.</given-names></name><name><surname>Au</surname><given-names>E.</given-names></name><name><surname>Patel</surname><given-names>J. C.</given-names></name><name><surname>Kruglikov</surname><given-names>I.</given-names></name><name><surname>Markx</surname><given-names>S.</given-names></name><name><surname>Delorme</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission</article-title>. <source/>Nature
<volume>511</volume>, <fpage>236</fpage>–<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1038/nature13248</pub-id><pub-id pub-id-type="pmid">24870235</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohls</surname><given-names>G.</given-names></name><name><surname>Schulte-Rüther</surname><given-names>M.</given-names></name><name><surname>Nehrkorn</surname><given-names>B.</given-names></name><name><surname>Müller</surname><given-names>K.</given-names></name><name><surname>Fink</surname><given-names>G. R.</given-names></name><name><surname>Kamp-Becker</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Reward system dysfunction in autism spectrum disorders</article-title>. <source/>Soc. Cogn. Affect. Neurosci.
<volume>8</volume>, <fpage>565</fpage>–<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1093/scan/nss033</pub-id><pub-id pub-id-type="pmid">22419119</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>J. W.</given-names></name><name><surname>Lobo</surname><given-names>M. K.</given-names></name><name><surname>Chaudhury</surname><given-names>D.</given-names></name><name><surname>Labonté</surname><given-names>B.</given-names></name><name><surname>Friedman</surname><given-names>A.</given-names></name><name><surname>Heller</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Loss of BDNF signaling in D1R-expressing NAc neurons enhances morphine reward by reducing GABA inhibition</article-title>. <source/>Neuropsychopharmacology
<volume>39</volume>, <fpage>2646</fpage>–<lpage>2653</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2014.118</pub-id><pub-id pub-id-type="pmid">24853771</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koob</surname><given-names>G. F.</given-names></name><name><surname>Bloom</surname><given-names>F. E.</given-names></name></person-group> (<year>1988</year>). <article-title>Cellular and molecular mechanisms of drug dependence</article-title>. <source/>Science
<volume>242</volume>, <fpage>715</fpage>–<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1126/science.2903550</pub-id><pub-id pub-id-type="pmid">2903550</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kupchik</surname><given-names>Y. M.</given-names></name><name><surname>Brown</surname><given-names>R. M.</given-names></name><name><surname>Heinsbroek</surname><given-names>J. A.</given-names></name><name><surname>Lobo</surname><given-names>M. K.</given-names></name><name><surname>Schwartz</surname><given-names>D. J.</given-names></name><name><surname>Kalivas</surname><given-names>P. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Coding the direct/indirect pathways by D1 and D2 receptors is not valid for accumbens projections</article-title>. <source/>Nat. Neurosci.
<volume>18</volume>, <fpage>1230</fpage>–<lpage>1232</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4068</pub-id><pub-id pub-id-type="pmid">26214370</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>C. H.</given-names></name><name><surname>Luikart</surname><given-names>B. W.</given-names></name><name><surname>Powell</surname><given-names>C. M.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Matheny</surname><given-names>S. A.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Pten regulates neuronal arborization and social interaction in mice</article-title>. <source/>Neuron
<volume>50</volume>, <fpage>377</fpage>–<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.03.023</pub-id><pub-id pub-id-type="pmid">16675393</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langen</surname><given-names>M.</given-names></name><name><surname>Bos</surname><given-names>D.</given-names></name><name><surname>Noordermeer</surname><given-names>S. D.</given-names></name><name><surname>Nederveen</surname><given-names>H.</given-names></name><name><surname>Van Engeland</surname><given-names>H.</given-names></name><name><surname>Durston</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Changes in the development of striatum are involved in repetitive behavior in autism</article-title>. <source/>Biol. Psychiatry
<volume>76</volume>, <fpage>405</fpage>–<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.08.013</pub-id><pub-id pub-id-type="pmid">24090791</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langen</surname><given-names>M.</given-names></name><name><surname>Durston</surname><given-names>S.</given-names></name><name><surname>Staal</surname><given-names>W. G.</given-names></name><name><surname>Palmen</surname><given-names>S. J.</given-names></name><name><surname>Van Engeland</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism</article-title>. <source/>Biol. Psychiatry
<volume>62</volume>, <fpage>262</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.09.040</pub-id><pub-id pub-id-type="pmid">17224135</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langen</surname><given-names>M.</given-names></name><name><surname>Leemans</surname><given-names>A.</given-names></name><name><surname>Johnston</surname><given-names>P.</given-names></name><name><surname>Ecker</surname><given-names>C.</given-names></name><name><surname>Daly</surname><given-names>E.</given-names></name><name><surname>Murphy</surname><given-names>C. M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Fronto-striatal circuitry and inhibitory control in autism: findings from diffusion tensor imaging tractography</article-title>. <source/>Cortex
<volume>48</volume>, <fpage>183</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/j.cortex.2011.05.018</pub-id><pub-id pub-id-type="pmid">21718979</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langen</surname><given-names>M.</given-names></name><name><surname>Schnack</surname><given-names>H. G.</given-names></name><name><surname>Nederveen</surname><given-names>H.</given-names></name><name><surname>Bos</surname><given-names>D.</given-names></name><name><surname>Lahuis</surname><given-names>B. E.</given-names></name><name><surname>De Jonge</surname><given-names>M. V.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Changes in the developmental trajectories of striatum in autism</article-title>. <source/>Biol. Psychiatry
<volume>66</volume>, <fpage>327</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.03.017</pub-id><pub-id pub-id-type="pmid">19423078</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levitt</surname><given-names>J. G.</given-names></name><name><surname>O'Neill</surname><given-names>J.</given-names></name><name><surname>Blanton</surname><given-names>R. E.</given-names></name><name><surname>Smalley</surname><given-names>S.</given-names></name><name><surname>Fadale</surname><given-names>D.</given-names></name><name><surname>McCracken</surname><given-names>J. T.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Proton magnetic resonance spectroscopic imaging of the brain in childhood autism</article-title>. <source/>Biol. Psychiatry
<volume>54</volume>, <fpage>1355</fpage>–<lpage>1366</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3223(03)00688-7</pub-id><pub-id pub-id-type="pmid">14675799</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Aragona</surname><given-names>B. J.</given-names></name><name><surname>Young</surname><given-names>K. A.</given-names></name><name><surname>Dietz</surname><given-names>D. M.</given-names></name><name><surname>Kabbaj</surname><given-names>M.</given-names></name><name><surname>Mazei-Robison</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Nucleus accumbens dopamine mediates amphetamine-induced impairment of social bonding in a monogamous rodent species</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>107</volume>, <fpage>1217</fpage>–<lpage>1222</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0911998107</pub-id><pub-id pub-id-type="pmid">20080553</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobo</surname><given-names>M. K.</given-names></name><name><surname>Covington</surname><given-names>H. E.</given-names><suffix>III</suffix></name><name><surname>Chaudhury</surname><given-names>D.</given-names></name><name><surname>Friedman</surname><given-names>A. K.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Damez-Werno</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward</article-title>. <source/>Science
<volume>330</volume>, <fpage>385</fpage>–<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1126/science.1188472</pub-id><pub-id pub-id-type="pmid">20947769</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maccarrone</surname><given-names>M.</given-names></name><name><surname>Rossi</surname><given-names>S.</given-names></name><name><surname>Bari</surname><given-names>M.</given-names></name><name><surname>De Chiara</surname><given-names>V.</given-names></name><name><surname>Rapino</surname><given-names>C.</given-names></name><name><surname>Musella</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA</article-title>. <source/>Neuropsychopharmacology
<volume>35</volume>, <fpage>1500</fpage>–<lpage>1509</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2010.19</pub-id><pub-id pub-id-type="pmid">20393458</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthes</surname><given-names>H. W.</given-names></name><name><surname>Maldonado</surname><given-names>R.</given-names></name><name><surname>Simonin</surname><given-names>F.</given-names></name><name><surname>Valverde</surname><given-names>O.</given-names></name><name><surname>Slowe</surname><given-names>S.</given-names></name><name><surname>Kitchen</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene</article-title>. <source/>Nature
<volume>383</volume>, <fpage>819</fpage>–<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1038/383819a0</pub-id><pub-id pub-id-type="pmid">8893006</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarroll</surname><given-names>S. A.</given-names></name><name><surname>Hyman</surname><given-names>S. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology</article-title>. <source/>Neuron
<volume>80</volume>, <fpage>578</fpage>–<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.046</pub-id><pub-id pub-id-type="pmid">24183011</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendez</surname><given-names>M. A.</given-names></name><name><surname>Horder</surname><given-names>J.</given-names></name><name><surname>Myers</surname><given-names>J.</given-names></name><name><surname>Coghlan</surname><given-names>S.</given-names></name><name><surname>Stokes</surname><given-names>P.</given-names></name><name><surname>Erritzoe</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study</article-title>. <source/>Neuropharmacology
<volume>68</volume>, <fpage>195</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.04.008</pub-id><pub-id pub-id-type="pmid">22546616</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moles</surname><given-names>A.</given-names></name><name><surname>Kieffer</surname><given-names>B. L.</given-names></name><name><surname>D'Amato</surname><given-names>F. R.</given-names></name></person-group> (<year>2004</year>). <article-title>Deficit in attachment behavior in mice lacking the mu-opioid receptor gene</article-title>. <source/>Science
<volume>304</volume>, <fpage>1983</fpage>–<lpage>1986</lpage>. <pub-id pub-id-type="doi">10.1126/science.1095943</pub-id><pub-id pub-id-type="pmid">15218152</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakatani</surname><given-names>J.</given-names></name><name><surname>Tamada</surname><given-names>K.</given-names></name><name><surname>Hatanaka</surname><given-names>F.</given-names></name><name><surname>Ise</surname><given-names>S.</given-names></name><name><surname>Ohta</surname><given-names>H.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism</article-title>. <source/>Cell
<volume>137</volume>, <fpage>1235</fpage>–<lpage>1246</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.04.024</pub-id><pub-id pub-id-type="pmid">19563756</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>A. B.</given-names></name><name><surname>Kreitzer</surname><given-names>A. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Reassessing models of basal ganglia function and dysfunction</article-title>. <source/>Annu. Rev. Neurosci.
<volume>37</volume>, <fpage>117</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-071013-013916</pub-id><pub-id pub-id-type="pmid">25032493</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nestler</surname><given-names>E. J.</given-names></name><name><surname>Hyman</surname><given-names>S. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Animal models of neuropsychiatric disorders</article-title>. <source/>Nat. Neurosci.
<volume>13</volume>, <fpage>1161</fpage>–<lpage>1169</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2647</pub-id><pub-id pub-id-type="pmid">20877280</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuhofer</surname><given-names>D.</given-names></name><name><surname>Henstridge</surname><given-names>C. M.</given-names></name><name><surname>Dudok</surname><given-names>B.</given-names></name><name><surname>Sepers</surname><given-names>M.</given-names></name><name><surname>Lassalle</surname><given-names>O.</given-names></name><name><surname>Katona</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Functional and structural deficits at accumbens synapses in a mouse model of Fragile X</article-title>. <source/>Front. Cell. Neurosci.
<volume>9</volume>:<issue>100</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00100</pub-id><pub-id pub-id-type="pmid">25859182</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves-Pereira</surname><given-names>M.</given-names></name><name><surname>Muller</surname><given-names>B.</given-names></name><name><surname>Massie</surname><given-names>D.</given-names></name><name><surname>Williams</surname><given-names>J. H.</given-names></name><name><surname>O'Brien</surname><given-names>P. C.</given-names></name><name><surname>Hughes</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Deregulation of EIF4E: a novel mechanism for autism</article-title>. <source/>J. Med. Genet.
<volume>46</volume>, <fpage>759</fpage>–<lpage>765</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2009.066852</pub-id><pub-id pub-id-type="pmid">19556253</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olazábal</surname><given-names>D. E.</given-names></name><name><surname>Young</surname><given-names>L. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Species and individual differences in juvenile female alloparental care are associated with oxytocin receptor density in the striatum and the lateral septum</article-title>. <source/>Horm. Behav.
<volume>49</volume>, <fpage>681</fpage>–<lpage>687</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2005.12.010</pub-id><pub-id pub-id-type="pmid">16442534</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panksepp</surname><given-names>J. B.</given-names></name><name><surname>Lahvis</surname><given-names>G. P.</given-names></name></person-group> (<year>2007</year>). <article-title>Social reward among juvenile mice</article-title>. <source/>Genes Brain Behav.
<volume>6</volume>, <fpage>661</fpage>–<lpage>671</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2006.00295.x</pub-id><pub-id pub-id-type="pmid">17212648</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascoli</surname><given-names>V.</given-names></name><name><surname>Terrier</surname><given-names>J.</given-names></name><name><surname>Espallergues</surname><given-names>J.</given-names></name><name><surname>Valjent</surname><given-names>E.</given-names></name><name><surname>O'Connor</surname><given-names>E. C.</given-names></name><name><surname>Luscher</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Contrasting forms of cocaine-evoked plasticity control components of relapse</article-title>. <source/>Nature
<volume>509</volume>, <fpage>459</fpage>–<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1038/nature13257</pub-id><pub-id pub-id-type="pmid">24848058</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascoli</surname><given-names>V.</given-names></name><name><surname>Turiault</surname><given-names>M.</given-names></name><name><surname>Lüscher</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour</article-title>. <source/>Nature
<volume>481</volume>, <fpage>71</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1038/nature10709</pub-id><pub-id pub-id-type="pmid">22158102</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peca</surname><given-names>J.</given-names></name><name><surname>Feliciano</surname><given-names>C.</given-names></name><name><surname>Ting</surname><given-names>J. T.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Wells</surname><given-names>M. F.</given-names></name><name><surname>Venkatraman</surname><given-names>T. N.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction</article-title>. <source/>Nature
<volume>472</volume>, <fpage>437</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1038/nature09965</pub-id><pub-id pub-id-type="pmid">21423165</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peñagarikano</surname><given-names>O.</given-names></name><name><surname>Abrahams</surname><given-names>B. S.</given-names></name><name><surname>Herman</surname><given-names>E. I.</given-names></name><name><surname>Winden</surname><given-names>K. D.</given-names></name><name><surname>Gdalyahu</surname><given-names>A.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits</article-title>. <source/>Cell
<volume>147</volume>, <fpage>235</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.08.040</pub-id><pub-id pub-id-type="pmid">21962519</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perreault</surname><given-names>M. L.</given-names></name><name><surname>Hasbi</surname><given-names>A.</given-names></name><name><surname>O'Dowd</surname><given-names>B. F.</given-names></name><name><surname>George</surname><given-names>S. R.</given-names></name></person-group> (<year>2011</year>). <article-title>The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia</article-title>. <source/>Front. Neuroanat.
<volume>5</volume>:<issue>31</issue>. <pub-id pub-id-type="doi">10.3389/fnana.2011.00031</pub-id><pub-id pub-id-type="pmid">21747759</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieretti</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>F. P.</given-names></name><name><surname>Fu</surname><given-names>Y. H.</given-names></name><name><surname>Warren</surname><given-names>S. T.</given-names></name><name><surname>Oostra</surname><given-names>B. A.</given-names></name><name><surname>Caskey</surname><given-names>C. T.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>Absence of expression of the FMR-1 gene in fragile X syndrome</article-title>. <source/>Cell
<volume>66</volume>, <fpage>817</fpage>–<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(91)90125-I</pub-id><pub-id pub-id-type="pmid">1878973</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portmann</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Mao</surname><given-names>R.</given-names></name><name><surname>Panagiotakos</surname><given-names>G.</given-names></name><name><surname>Ellegood</surname><given-names>J.</given-names></name><name><surname>Dolen</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Behavioral abnormalities and circuit defects in the basal ganglia of a mouse model of 16p11.2 deletion syndrome</article-title>. <source/>Cell Rep.
<volume>7</volume>, <fpage>1077</fpage>–<lpage>1092</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.03.036</pub-id><pub-id pub-id-type="pmid">24794428</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resendez</surname><given-names>S. L.</given-names></name><name><surname>Dome</surname><given-names>M.</given-names></name><name><surname>Gormley</surname><given-names>G.</given-names></name><name><surname>Franco</surname><given-names>D.</given-names></name><name><surname>Nevárez</surname><given-names>N.</given-names></name><name><surname>Hamid</surname><given-names>A. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>mu-Opioid receptors within subregions of the striatum mediate pair bond formation through parallel yet distinct reward mechanisms</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>9140</fpage>–<lpage>9149</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4123-12.2013</pub-id><pub-id pub-id-type="pmid">23699524</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richey</surname><given-names>J. A.</given-names></name><name><surname>Rittenberg</surname><given-names>A.</given-names></name><name><surname>Hughes</surname><given-names>L.</given-names></name><name><surname>Damiano</surname><given-names>C. R.</given-names></name><name><surname>Sabatino</surname><given-names>A.</given-names></name><name><surname>Miller</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Common and distinct neural features of social and non-social reward processing in autism and social anxiety disorder</article-title>. <source/>Soc. Cogn. Affect. Neurosci.
<volume>9</volume>, <fpage>367</fpage>–<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1093/scan/nss146</pub-id><pub-id pub-id-type="pmid">23223206</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>T. E.</given-names></name><name><surname>Berridge</surname><given-names>K. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Review. The incentive sensitization theory of addiction: some current issues</article-title>. <source/>Philos. Trans. R. Soc. Lond. B. Biol. Sci.
<volume>363</volume>, <fpage>3137</fpage>–<lpage>3146</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.2008.0093</pub-id><pub-id pub-id-type="pmid">18640920</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>D. C.</given-names></name><name><surname>Peterson</surname><given-names>E.</given-names></name><name><surname>Winterrowd</surname><given-names>E.</given-names></name><name><surname>Reite</surname><given-names>M. L.</given-names></name><name><surname>Rogers</surname><given-names>S. J.</given-names></name><name><surname>Tregellas</surname><given-names>J. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Regional gray matter volumetric changes in autism associated with social and repetitive behavior symptoms</article-title>. <source/>BMC Psychiatry
<volume>6</volume>:<fpage>56</fpage>. <pub-id pub-id-type="doi">10.1186/1471-244X-6-56</pub-id><pub-id pub-id-type="pmid">17166273</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothwell</surname><given-names>P. E.</given-names></name><name><surname>Fuccillo</surname><given-names>M. V.</given-names></name><name><surname>Maxeiner</surname><given-names>S.</given-names></name><name><surname>Hayton</surname><given-names>S. J.</given-names></name><name><surname>Gokce</surname><given-names>O.</given-names></name><name><surname>Lim</surname><given-names>B. K.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors</article-title>. <source/>Cell
<volume>158</volume>, <fpage>198</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.04.045</pub-id><pub-id pub-id-type="pmid">24995986</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>S. J.</given-names></name><name><surname>Dietz</surname><given-names>D. M.</given-names></name><name><surname>Dumitriu</surname><given-names>D.</given-names></name><name><surname>Morrison</surname><given-names>J. H.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name><name><surname>Nestler</surname><given-names>E. J.</given-names></name></person-group> (<year>2010</year>). <article-title>The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens</article-title>. <source/>Trends Neurosci.
<volume>33</volume>, <fpage>267</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2010.02.002</pub-id><pub-id pub-id-type="pmid">20207024</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salamone</surname><given-names>J. D.</given-names></name><name><surname>Correa</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>The mysterious motivational functions of mesolimbic dopamine</article-title>. <source/>Neuron
<volume>76</volume>, <fpage>470</fpage>–<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.10.021</pub-id><pub-id pub-id-type="pmid">23141060</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santini</surname><given-names>E.</given-names></name><name><surname>Huynh</surname><given-names>T. N.</given-names></name><name><surname>Macaskill</surname><given-names>A. F.</given-names></name><name><surname>Carter</surname><given-names>A. G.</given-names></name><name><surname>Pierre</surname><given-names>P.</given-names></name><name><surname>Ruggero</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Exaggerated translation causes synaptic and behavioural aberrations associated with autism</article-title>. <source/>Nature
<volume>493</volume>, <fpage>411</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1038/nature11782</pub-id><pub-id pub-id-type="pmid">23263185</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarnyai</surname><given-names>Z.</given-names></name><name><surname>Kovacs</surname><given-names>G. L.</given-names></name></person-group> (<year>1994</year>). <article-title>Role of oxytocin in the neuroadaptation to drugs of abuse</article-title>. <source/>Psychoneuroendocrinology
<volume>19</volume>, <fpage>85</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4530(94)90062-0</pub-id><pub-id pub-id-type="pmid">9210215</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarnyai</surname><given-names>Z.</given-names></name><name><surname>Kovács</surname><given-names>G. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Oxytocin in learning and addiction: from early discoveries to the present</article-title>. <source/>Pharmacol. Biochem. Behav.
<volume>119</volume>, <fpage>3</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2013.11.019</pub-id><pub-id pub-id-type="pmid">24280016</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott-Van Zeeland</surname><given-names>A. A.</given-names></name><name><surname>Dapretto</surname><given-names>M.</given-names></name><name><surname>Ghahremani</surname><given-names>D. G.</given-names></name><name><surname>Poldrack</surname><given-names>R. A.</given-names></name><name><surname>Bookheimer</surname><given-names>S. Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Reward processing in autism</article-title>. <source/>Autism Res.
<volume>3</volume>, <fpage>53</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1002/aur.122</pub-id><pub-id pub-id-type="pmid">20437601</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sears</surname><given-names>L. L.</given-names></name><name><surname>Vest</surname><given-names>C.</given-names></name><name><surname>Mohamed</surname><given-names>S.</given-names></name><name><surname>Bailey</surname><given-names>J.</given-names></name><name><surname>Ranson</surname><given-names>B. J.</given-names></name><name><surname>Piven</surname><given-names>J.</given-names></name></person-group> (<year>1999</year>). <article-title>An MRI study of the basal ganglia in autism</article-title>. <source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
<volume>23</volume>, <fpage>613</fpage>–<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1016/S0278-5846(99)00020-2</pub-id><pub-id pub-id-type="pmid">10390720</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sesack</surname><given-names>S. R.</given-names></name><name><surname>Grace</surname><given-names>A. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Cortico-Basal Ganglia reward network: microcircuitry</article-title>. <source/>Neuropsychopharmacology
<volume>35</volume>, <fpage>27</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2009.93</pub-id><pub-id pub-id-type="pmid">19675534</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shuen</surname><given-names>J. A.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Gloss</surname><given-names>B.</given-names></name><name><surname>Calakos</surname><given-names>N.</given-names></name></person-group> (<year>2008</year>). <article-title>Drd1a-tdTomato BAC transgenic mice for simultaneous visualization of medium spiny neurons in the direct and indirect pathways of the basal ganglia</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>2681</fpage>–<lpage>2685</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5492-07.2008</pub-id><pub-id pub-id-type="pmid">18337395</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silk</surname><given-names>T. J.</given-names></name><name><surname>Rinehart</surname><given-names>N.</given-names></name><name><surname>Bradshaw</surname><given-names>J. L.</given-names></name><name><surname>Tonge</surname><given-names>B.</given-names></name><name><surname>Egan</surname><given-names>G.</given-names></name><name><surname>O'Boyle</surname><given-names>M. W.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Visuospatial processing and the function of prefrontal-parietal networks in autism spectrum disorders: a functional MRI study</article-title>. <source/>Am. J. Psychiatry
<volume>163</volume>, <fpage>1440</fpage>–<lpage>1443</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.2006.163.8.1440</pub-id><pub-id pub-id-type="pmid">16877661</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>J. L.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Lord</surname><given-names>C.</given-names></name><name><surname>Crawley</surname><given-names>J. N.</given-names></name></person-group> (<year>2010</year>). <article-title>Behavioural phenotyping assays for mouse models of autism</article-title>. <source/>Nat. Rev. Neurosci.
<volume>11</volume>, <fpage>490</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2851</pub-id><pub-id pub-id-type="pmid">20559336</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>S.</given-names></name><name><surname>McGovern</surname><given-names>R. A.</given-names></name><name><surname>Sheth</surname><given-names>S. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Deep brain stimulation for severe autism: from pathophysiology to procedure</article-title>. <source/>Neurosurg. Focus
<volume>38</volume>, <fpage>E3</fpage>. <pub-id pub-id-type="doi">10.3171/2015.3.FOCUS1548</pub-id><pub-id pub-id-type="pmid">26030703</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>L. N.</given-names></name><name><surname>Jedynak</surname><given-names>J. P.</given-names></name><name><surname>Fontenot</surname><given-names>M. R.</given-names></name><name><surname>Hale</surname><given-names>C. F.</given-names></name><name><surname>Dietz</surname><given-names>K. C.</given-names></name><name><surname>Taniguchi</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Fragile X mental retardation protein regulates synaptic and behavioral plasticity to repeated cocaine administration</article-title>. <source/>Neuron
<volume>82</volume>, <fpage>645</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2014.03.028</pub-id><pub-id pub-id-type="pmid">24811383</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>R. J.</given-names></name><name><surname>Lobo</surname><given-names>M. K.</given-names></name><name><surname>Spencer</surname><given-names>S.</given-names></name><name><surname>Kalivas</surname><given-names>P. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways)</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>23</volume>, <fpage>546</fpage>–<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2013.01.026</pub-id><pub-id pub-id-type="pmid">23428656</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiegel</surname><given-names>I.</given-names></name><name><surname>Salomon</surname><given-names>D.</given-names></name><name><surname>Erne</surname><given-names>B.</given-names></name><name><surname>Schaeren-Wiemers</surname><given-names>N.</given-names></name><name><surname>Peles</surname><given-names>E.</given-names></name></person-group> (<year>2002</year>). <article-title>Caspr3 and caspr4, two novel members of the caspr family are expressed in the nervous system and interact with PDZ domains</article-title>. <source/>Mol. Cell. Neurosci.
<volume>20</volume>, <fpage>283</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1006/mcne.2002.1110</pub-id><pub-id pub-id-type="pmid">12093160</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staal</surname><given-names>W. G.</given-names></name><name><surname>Langen</surname><given-names>M.</given-names></name><name><surname>Van Dijk</surname><given-names>S.</given-names></name><name><surname>Mensen</surname><given-names>V. T.</given-names></name><name><surname>Durston</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>DRD3 gene and striatum in autism spectrum disorder</article-title>. <source/>Br. J. Psychiatry
<volume>206</volume>, <fpage>431</fpage>–<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.114.148973</pub-id><pub-id pub-id-type="pmid">25792691</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sturm</surname><given-names>V.</given-names></name><name><surname>Fricke</surname><given-names>O.</given-names></name><name><surname>Buhrle</surname><given-names>C. P.</given-names></name><name><surname>Lenartz</surname><given-names>D.</given-names></name><name><surname>Maarouf</surname><given-names>M.</given-names></name><name><surname>Treuer</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>DBS in the basolateral amygdala improves symptoms of autism and related self-injurious behavior: a case report and hypothesis on the pathogenesis of the disorder</article-title>. <source/>Front. Hum. Neurosci.
<volume>6</volume>:<issue>341</issue>. <pub-id pub-id-type="doi">10.3389/fnhum.2012.00341</pub-id><pub-id pub-id-type="pmid">23346052</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>S. H.</given-names></name><name><surname>Kao</surname><given-names>F. C.</given-names></name><name><surname>Huang</surname><given-names>Y. B.</given-names></name><name><surname>Liao</surname><given-names>W.</given-names></name></person-group> (<year>2015</year>). <article-title>MeCP2 in the rostral striatum maintains local dopamine content critical for psychomotor control</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>6209</fpage>–<lpage>6220</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4624-14.2015</pub-id><pub-id pub-id-type="pmid">25878291</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Südhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Neuroligins and neurexins link synaptic function to cognitive disease</article-title>. <source/>Nature
<volume>455</volume>, <fpage>903</fpage>–<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1038/nature07456</pub-id><pub-id pub-id-type="pmid">18923512</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takarae</surname><given-names>Y.</given-names></name><name><surname>Minshew</surname><given-names>N. J.</given-names></name><name><surname>Luna</surname><given-names>B.</given-names></name><name><surname>Sweeney</surname><given-names>J. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Atypical involvement of frontostriatal systems during sensorimotor control in autism</article-title>. <source/>Psychiatry Res.
<volume>156</volume>, <fpage>117</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.pscychresns.2007.03.008</pub-id><pub-id pub-id-type="pmid">17913474</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trezza</surname><given-names>V.</given-names></name><name><surname>Damsteegt</surname><given-names>R.</given-names></name><name><surname>Achterberg</surname><given-names>E. J.</given-names></name><name><surname>Vanderschuren</surname><given-names>L. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Nucleus accumbens mu-opioid receptors mediate social reward</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>6362</fpage>–<lpage>6370</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5492-10.2011</pub-id><pub-id pub-id-type="pmid">21525276</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trezza</surname><given-names>V.</given-names></name><name><surname>Damsteegt</surname><given-names>R.</given-names></name><name><surname>Manduca</surname><given-names>A.</given-names></name><name><surname>Petrosino</surname><given-names>S.</given-names></name><name><surname>Van Kerkhof</surname><given-names>L. W.</given-names></name><name><surname>Pasterkamp</surname><given-names>R. J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>14899</fpage>–<lpage>14908</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0114-12.2012</pub-id><pub-id pub-id-type="pmid">23100412</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trezza</surname><given-names>V.</given-names></name><name><surname>Damsteegt</surname><given-names>R.</given-names></name><name><surname>Vanderschuren</surname><given-names>L. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Conditioned place preference induced by social play behavior: parametrics, extinction, reinstatement and disruption by methylphenidate</article-title>. <source/>Eur. Neuropsychopharmacol.
<volume>19</volume>, <fpage>659</fpage>–<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2009.03.006</pub-id><pub-id pub-id-type="pmid">19427175</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>K. C.</given-names></name><name><surname>Frost</surname><given-names>L.</given-names></name><name><surname>Linsenbardt</surname><given-names>D.</given-names></name><name><surname>McIlroy</surname><given-names>J. R.</given-names></name><name><surname>Müller</surname><given-names>R. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Atypically diffuse functional connectivity between caudate nuclei and cerebral cortex in autism</article-title>. <source/>Behav. Brain Funct.
<volume>2</volume>, <fpage>34</fpage>. <pub-id pub-id-type="doi">10.1186/1744-9081-2-34</pub-id><pub-id pub-id-type="pmid">17042953</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzschentke</surname><given-names>T. M.</given-names></name></person-group> (<year>1998</year>). <article-title>Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues</article-title>. <source/>Prog. Neurobiol.
<volume>56</volume>, <fpage>613</fpage>–<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1016/S0301-0082(98)00060-4</pub-id><pub-id pub-id-type="pmid">9871940</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderschuren</surname><given-names>L. J.</given-names></name><name><surname>Kalivas</surname><given-names>P. W.</given-names></name></person-group> (<year>2000</year>). <article-title>Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies</article-title>. <source/>Psychopharmacology (Berl.)
<volume>151</volume>, <fpage>99</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1007/s002130000493</pub-id><pub-id pub-id-type="pmid">10972458</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voelbel</surname><given-names>G. T.</given-names></name><name><surname>Bates</surname><given-names>M. E.</given-names></name><name><surname>Buckman</surname><given-names>J. F.</given-names></name><name><surname>Pandina</surname><given-names>G.</given-names></name><name><surname>Hendren</surname><given-names>R. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Caudate nucleus volume and cognitive performance: are they related in childhood psychopathology?</article-title>
<source/>Biol. Psychiatry
<volume>60</volume>, <fpage>942</fpage>–<lpage>950</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.03.071</pub-id><pub-id pub-id-type="pmid">16950212</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>L. J.</given-names></name><name><surname>Kim</surname><given-names>S. S.</given-names></name><name><surname>Lee</surname><given-names>F. J.</given-names></name><name><surname>Gong</surname><given-names>B.</given-names></name><name><surname>Toyoda</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>FMRP acts as a key messenger for dopamine modulation in the forebrain</article-title>. <source/>Neuron
<volume>59</volume>, <fpage>634</fpage>–<lpage>647</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.06.027</pub-id><pub-id pub-id-type="pmid">18760699</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>D.</given-names></name><name><surname>Cox</surname><given-names>C. D.</given-names></name><name><surname>Karsten</surname><given-names>C. A.</given-names></name><name><surname>Penagarikano</surname><given-names>O.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Endocannabinoid signaling mediates oxytocin-driven social reward</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>112</volume>, <fpage>14084</fpage>–<lpage>14089</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1509795112</pub-id><pub-id pub-id-type="pmid">26504214</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>L. A.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Korn</surname><given-names>J. M.</given-names></name><name><surname>Arking</surname><given-names>D. E.</given-names></name><name><surname>Miller</surname><given-names>D. T.</given-names></name><name><surname>Fossdal</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Association between microdeletion and microduplication at 16p11.2 and autism</article-title>. <source/>N. Engl. J. Med.
<volume>358</volume>, <fpage>667</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa075974</pub-id><pub-id pub-id-type="pmid">18184952</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whittemore</surname><given-names>R.</given-names></name><name><surname>Chao</surname><given-names>A.</given-names></name><name><surname>Jang</surname><given-names>M.</given-names></name><name><surname>Minges</surname><given-names>K. E.</given-names></name><name><surname>Park</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Methods for knowledge synthesis: an overview</article-title>. <source/>Heart Lung
<volume>43</volume>, <fpage>453</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1016/j.hrtlng.2014.05.014</pub-id><pub-id pub-id-type="pmid">25012634</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wise</surname><given-names>R. A.</given-names></name></person-group> (<year>1987</year>). <article-title>The role of reward pathways in the development of drug dependence</article-title>. <source/>Pharmacol. Ther.
<volume>35</volume>, <fpage>227</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1016/0163-7258(87)90108-2</pub-id><pub-id pub-id-type="pmid">3321101</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wise</surname><given-names>R. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Dopamine, learning and motivation</article-title>. <source/>Nat. Rev. Neurosci.
<volume>5</volume>, <fpage>483</fpage>–<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1406</pub-id><pub-id pub-id-type="pmid">15152198</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y.</given-names></name><name><surname>Driscoll</surname><given-names>J. R.</given-names></name><name><surname>Wilbrecht</surname><given-names>L.</given-names></name><name><surname>Margolis</surname><given-names>E. B.</given-names></name><name><surname>Fields</surname><given-names>H. L.</given-names></name><name><surname>Hjelmstad</surname><given-names>G. O.</given-names></name></person-group> (<year>2011</year>). <article-title>Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>7811</fpage>–<lpage>7816</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1504-11.2011</pub-id><pub-id pub-id-type="pmid">21613494</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasue</surname><given-names>H.</given-names></name><name><surname>Yee</surname><given-names>J. R.</given-names></name><name><surname>Hurlemann</surname><given-names>R.</given-names></name><name><surname>Rilling</surname><given-names>J. K.</given-names></name><name><surname>Chen</surname><given-names>F. S.</given-names></name><name><surname>Meyer-Lindenberg</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Integrative approaches utilizing oxytocin to enhance prosocial behavior: from animal and human social behavior to autistic social dysfunction</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>14109</fpage>–<lpage>14117</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3327-12.2012</pub-id><pub-id pub-id-type="pmid">23055480</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>H. H.</given-names></name><name><surname>Knowlton</surname><given-names>B. J.</given-names></name></person-group> (<year>2006</year>). <article-title>The role of the basal ganglia in habit formation</article-title>. <source/>Nat. Rev. Neurosci.
<volume>7</volume>, <fpage>464</fpage>–<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1919</pub-id><pub-id pub-id-type="pmid">16715055</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>K. A.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Gobrogge</surname><given-names>K. L.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group> (<year>2014</year>). <article-title>Oxytocin reverses amphetamine-induced deficits in social bonding: evidence for an interaction with nucleus accumbens dopamine</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>8499</fpage>–<lpage>8506</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4275-13.2014</pub-id><pub-id pub-id-type="pmid">24948805</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name><name><surname>Bear</surname><given-names>M. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities</article-title>. <source/>Cold Spring Harb. Perspect. Biol.
<volume>4</volume>:<fpage>a009886</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a009886</pub-id><pub-id pub-id-type="pmid">22258914</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>